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In 2018 the movie Rampage reached the big screens throughout the nation and the world.  
The main actor, good guy, and hero is Dwayne “The Rock” Johnson.  Like most of his movies, it 
is filled with action.  In this particular script, the villain is not a person or a gang, but three 
animals–a gorilla, a wolf and an alligator–that mutated to an enormous size and at the same time 
grew in strength and developed other traits.  These creatures destroyed the city of Chicago and 
everything they found on their way.  What happened to them that caused this mutation?  It was 
CRISPR.  In a popular non-scientific approach, the story of the movie has CRISPR as the new 
genetic tool that can cause these incredible changes in the body without any control just by being 
exposed to it.  Unfortunately, some people, when sitting in front of the screen, and watching 
Hollywood’s creations and imagination, process some of the contents as if it was a documentary.  
In their minds, these films can become the source of truth and learning about science and even 
theology.  This is what I witnessed personally when youth and adults approached me with 
questions regarding religious beliefs based on movies.  Two other vivid examples concerned 
with what they saw, heard, and then believed as true from the movies are Stigmata and The 
DaVinci Code.  
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 Acknowledging the possible misunderstandings of genetic editing, I consider it important 
and necessary to demystify any trends that canonize or demonize genetic editing, particularly 
CRISPR/Cas9.  To the best of my ability, I discuss what it is and what it is not with the lenses of 
science and religion. 
 During the last hundred years, scientific research has become even more fascinating and 
daring than before, because it has been able to literally reach into what was considered part of the 
unseen world.  The knowledge about the human body and its genetic constitution greatly 
increased.  The fact that scientists can now determine the information related to what is 
considered to be the healthy condition for a person, allows them to approach illnesses from a 
different point of view.  For the longest time, illnesses were treated exclusively with medicines 
that could overcome diseases, or in some cases only slow them down and prevent them from 
getting worse.  Medicines were found in nature and more recently created and produced in a lab.  
In research labs, the newer approaches imply discovering illnesses and remedies that are 
genetically based.  More and more, the focus is on structural damage and repair.  The hope of 
researchers is to obtain results that are long term and truly effective in restoring or assuring the 
good health of the individual.   
Genetic editing treatments are for genetic illnesses and conditions.  The following are 
some examples of which diseases could be targeted and which cannot be targets for research. 
Genetic illnesses:       Non-genetic illnesses: 
 Cystic fibrosis     Kidney failure 
 Sickle cell anemia    AIDS 
 Huntington’s disease    Tuberculosis 
 Coronary artery disease   Cirrhosis  




Within genetic illnesses there are different categories.  An overarching category is 
whether the disease depends on a single gene mutation or various mutations in different genes.  
Clearly, the number of mutations and locations will determine how difficult or realistic it will be 
to try to correct them.  Moreover, it is necessary to assess whether the mutation is the direct 
cause of the illness or if it predisposes to it or increases the risk to suffer from the disease.  In the 
field of genetics, the more scientific research is done, the more connections researchers find 
between a certain illness and its genetic etiology.  In some cases, the person is born with a 
mutation, in others the exposure to things in the environment caused the mutation.  And as I 
mentioned earlier, in many situations it is the actual genetic makeup of the individual that makes 
the person more susceptible to contracting a certain disease.  
Moreover, we need to acknowledge the shift in services and goods provided.  For the 
longest time in human history, the economy aimed at providing external goods to people.  These 
goods, these objects were changing and improving.  Notice for example, the ongoing 
modification of cars to make them more efficient and comfortable, with more accessories and 
safer for the passengers.  In the last couple of centuries, technology is still looking to make 
‘things’ faster, smaller or stronger, but at the same time it searched for ways to improve the 
actual human body.  The latter can be seen in the prevention of illnesses (vaccination), providing 
healing from a condition (pacemaker), supplying artifacts to overcome a handicap (prosthesis) or 
changing a ‘defect’ (corrective surgery).  The next step of these improvements seems to be the 
human body itself.   
Our present Western philosophy of life and our understanding of the human body are too 
complex to be narrowed into one general concept.  As we look back, what can be highlighted are 
two events that greatly influenced genetic experimentation.  The first one is the theory of 
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evolution which acknowledges that the living species survive and strive by experiencing 
naturally an ongoing modification and adaptation.  Because these changes are considered to be 
random acts of nature, of which we have no control, there is an acceptance of the final results. 
The second event is the post Enlightment, with its emphasis on the individuality of the person.  
Previously, some societies focused only on the tribal needs; it was a collective approach.  Other 
societies attended only to the aristocrats and those in position of power, while others in the 
community had no voice and no rights.  In this post Enlightment era there has been a greater 
focus on the individual’s rights and autonomy.1   
 Maybe due to the influence of science fiction movies or just the lack of scientific 
knowledge, some people are opposed to anything that tampers the human genes, or any other 
gene.  Besides fear of the unknown, some religious values prohibit any tampering of the body, 
even in the case of blood transfusion.  Other people are inspired by the spirit of consumerism and 
innovation and are quickly receptive to anything new, but often they do not know what are the 
actual implications and long-term effects of many changes.  We can see this struggle for 
consumption every day.  Some people do not mind eating ‘genetically modified’ products 
because of their lower cost, while others are demanding that their products be ‘organic’. 
 This thesis studies genetic editing by focusing on the technique, its possible uses, and its 
moral implications.  Even though I am a science lover, it took me some extra time to truly grasp 
what is gene editing.  Therefore, on the one hand, one of my objectives is to illustrate what gene 
editing is in the simplest way.  The scientific contents cannot be omitted from the discussion if 
we are about to make a conscientious judgment; it is part of being well informed.  On the other 
                                                          
1 See Nikolaos Koios, “Theological Anthropology and Human Germ-Line Intervention,” Christian Bioethics 18, no. 
2 (2012): 189. 
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hand, this is a thesis in theology and not a scientific dissertation; therefore it will not go into 
profound depth to examine techniques and illnesses. 
  In our world, where so much is happening in genetics, this paper is focusing on genetic 
editing, particularly the technique of CRISPR/Cas9.  Genetic editing is the technique that allows 
to add, delete, or alter a gene.  The genes hold the genetic information of the organism, and 
provide all the instructions regarding the tissues, the organs, and finally the body.  Editing is 
different from gene therapy; the former is changing a segment within the gene, and the latter is 
an actual insertion of a new and healthy gene into the organism.2  Researchers of both techniques 
are aiming at clinical trials; so far the gene editing is not fully approved by the US FDA.3  
 Genetic editing, as with almost all other research, began with other organisms such as 
plants and animals.  The key question that scientists are asking is: could genetic editing become 
the yet missing treatment to heal or prevent certain diseases or disabilities that so far have no 
therapy? 
 Several techniques for gene editing have been created, among them meganucleases, Ztns, 
and TALENs.  But in the last few years, the scientific world has shown great excitement (and 
hope) with CRISPR/Cas9.  Because of its expected precision and efficiency, and because it is a 
less expensive technique, it may be the best success story in genetic research at the present time. 
 What determines the power of one genome editing technique over the other?  What 
would make it a success story?  The ideal technique could be applied to any cell of the organism.  
It should be precise in targeting a section of the gene.  It is expected to be efficient /reliable in 
finding the target by leaving no traces of a foreign DNA and simple to replicate in any lab and 
                                                          
2 See National Academy of Sciences, Engineering, and Medicine, Human Genome Editing: Science, Ethics, and 
Governance (Washington, D.C.: The National Academy Press, 2017), 12. 
3 See ibid., 13. 
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therefore cost effective.4  CRIPR/Cas9 seems to have all those advantages.  Some call it the 
“perfect molecular scissors.” 5 
Scientists have been able to recognize over 7,000 monogenetic disorders.  These 
phenotype ‘imperfections’ are for the most part harmless.6  The point is that it is common for a 
person to have genetic defects.  Some of the consequences of these defects can be addressed with 
drugs.  What is problematic is when they are not that easy to correct.    
 Moral theology holds in a prime position the role of conscience in the decision making of 
the individual.  It is there where persons encounter the spirit of God that guides them.  No moral 
agents should go against their conscience.  The primacy of the conscience is based on being well 
formed and properly educated.  Persons should take advantage of many resources, written or 
verbal, to enlighten their understanding on specific issues.  But also there is a need to pray asking 
for the assistance of the gifts of the Holy Spirit.  Therefore, in these pages I look deeper into the 
human body to grasp the creative power we have received by being made in the image and 
likeness of God, praying for divine wisdom in order to make not just good decisions but the best 
moral decisions for our own selves, and also for all our brothers and sisters. 
 Unfortunately, within all levels of education people believe that the Catholic Church is 
against any scientific progress.  The Congregation of the Doctrine of the Faith, in the instruction 
Dignitas personae: On Certain Bioethical Questions, reminds the world that the Church’s 
Magisterium does not take an antagonistic position towards science.  In appreciation of scientific 
achievements, the Magisterium insists in keeping a balance within genetic research.  On the one 
hand, it is important to encourage and to support scientific research because it allows to improve 
                                                          
4 See John Parrington, Redesigning Life: How Genome Editing will Transform the World (Oxford: Oxford 
University Press, 2016), 83. 
5 See ibid., 84. 
6 See Philip R. Reilly, Orphan: The Quest to Save Children with Rare Genetic Disorders (Cold Spring Harbor, NY: 
Cold Spring Harbor Laboratory Press, 2015), 281. 
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the quality of human life.7  On the other hand, the community must be cautious and assess 
wether this research is truly opened to all peoples and respects the dignity of every person.  Our 
human history has shown great accomplishments by conquering illnesses and discovering drugs 
and treatments.  But our history has also shown terrible abuses suffered by races, groups, ages 
and in various stages of life for the sake of science.  Hence, “The introduction of discrimination 
with regard to human dignity based on biological, psychological, or educational development, or 
based on health-related criteria, must be excluded.”8 
 Pope Benedict XVI, in his encyclical letter Caritas in veritate reminds the entire world, 
believers and non-believers, of the interconnectedness between truth and charity.  One impacts 
the other and, in particular, searching for scientific truths charity should prevail.   
Technology enables us to exercise dominion over matter, to reduce risks, to save 
labour, to improve our conditions of life.  It touches the heart of the vocation of 
human labour: in technology, seen as the product of his genius, man recognizes 
himself and forges his own humanity.  Technology is the objective side of human 
action whose origin and raison d'etre is found in the subjective element: the 
worker himself.  For this reason, technology is never merely technology.  It 
reveals man and his aspirations towards development, it expresses the inner 
tension that impels him gradually to overcome material limitations.  Technology, 
in this sense, is a response to God’s command to till and to keep the land (cf. Gen 
2:15) that he has entrusted to humanity, and it must serve to reinforce the 
covenant between human beings and the environment, a covenant that should 
mirror God's creative love.9 
 
For those in seminaries and parishes, labs and hospitals we should remind “that moral 
evaluation and scientific research must go hand in hand, and that charity must animate them in a 
harmonious interdisciplinary whole, marked by unity and distinction.”10 
 
                                                          
7 See Congregation for the Doctrine of the Faith, Dignitas personae: On Certain Bioethical Questions, (2008), no. 3. 
8 Ibid., no. 8. 
9 Benedict XVI, Caritas in veritate (2009), no. 69. 










CRISPR/Cas9 and somatic illnesses 
 
Our journey takes us deep into the human body, into the cells, into the chromosomes 
where we find the genes.  Genes are the information map of the organism and they are present in 
every cell.  The genes are formed by the DNA which is a double helix that consists of a sequence 
of nucleotides and those sequences define a characteristic or function of the cell.  Nucleotides are 
the basic units of the DNA, and there are four different ones:  Adenine (A), Cytosine (C), 
Guanine (G) and Thymine (T).  They bond to each other as pairs, limited to an A-T and G-C 
combination.  Once they are lined up they create the double helix.  Figure 1 shows the location of 




Figure 1.  Location of the DNA.11 
The expression of the information code within the DNA is accomplished by the RNA.12  
The RNA is a nucleotide polymer that copies the sequences of A, C, G and T from the DNA and 
translates those codes in order to produce proteins.  Proteins are polymers made of a combination 
of 20 different aminoacids, in contrast to the RNA that is formed by the combination of only four 
bases.  The proteins contribute to cell functioning and cells form the different organs and tissues 
of the whole body.  This entire map or set of instructions on how to build up the body is called 
the human genome.  Presently the human genome is estimated to contain three billion pair bases 
that can be translated into approximately 20,000 proteins.13  Figure 2 shows the difference and 
similarity between the DNA and RNA. 
                                                          
11 Britannica Learn, last accessed October 28, 2019, 
https://twitter.com/britannicalearn/status/789510420197408768?lang=en. 
12 “Ribonucleic acid (RNA) is a molecule similar to DNA. Unlike DNA, RNA is single-stranded. An RNA strand 
has a backbone made of alternating sugar (ribose) and phosphate groups. Attached to each sugar is one of four 
bases– adenine (A), uracil (U), cytosine (C), or guanine (G). Different types of RNA exist in the cell: messenger 
RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). More recently, some small RNAs have been 
found to be involved in regulating gene expression.  https://www.genome.gov/genetics-glossary/RNA-Ribonucleic-
Acid. 




Figure 2.  DNA versus RNA.14 
A mutation is a change in the expected sequence of the nucleotides within a particular 
DNA.  They “can occur spontaneously during cell division or can be triggered by environmental 
stresses, such as sunlight, radiation, and chemicals”.15  These mutations can remain unnoticed 
throughout the life of the person, because they are harmless; or they can express themselves in a 
physical trait or condition. 
Therefore if the goal is to influence the body, a specific organ or function within the 
body, then one alternative is to go into the core, right to the genes.  At the present time, 
CRISPR/Cas9 is considered one of the most effective ways of bringing about the change needed.  
Cas9 (which stands for CRISPR associated protein 9) is a nuclease, which means that it is a 
protein that can cut the DNA or RNA.  Once a scenario for editing is chosen, Cas9 attaches to 
                                                          
14 DNA versus RNA, last accessed October 28, 2019, https://i2.wp.com/sciencesamhita.com/wp-
content/uploads/2016/03/dna-versus-rna.jpg?resize=672%2C372&ssl=1. 
15 National Academy, Human Genome Editing, 302. 
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the targeted DNA and cuts the segment of desired nucleotides.  When a segment is cut off, there 
are two main possibilities: one is that the two loose ends can reattach to each other 
(nonhomologous end joining, NHEJ);16 and the other is that a new segment with a new sequence 
of nucleotides can be added (homology-directed repair, HDR).17  If it is left to the DNA to repair 
itself, there is always the possibility of creating a new sequence, which could cause a new 
mutation and even disable the gene.  Therefore, to avoid negative or unhealthy results, the 
preferred option is to add a strand of RNA (half of the helix) with the desired or healthier 
sequence.  Once this RNA is in place, it will be completed naturally with the corresponding 
nucleotides to form the double helix.18 
Human proteins are produced within the cells, but Cas9 was originally found and 
produced in bacteria.  The actual technique of gene editing is called CRISPR/Cas9.  The name 
comes from clustered regularly interspaced short palindromic repeats.  It refers to short, repeated 
segments of DNA originally discovered in bacteria.19  The most commonly used and preferred 
CRISPR/Cas9 combination comes from the bacterium Streptococcus pyogenes.  Why bacteria?  
Scientists learned from the bacteria that in order to protect themselves, they take segments of the 
DNA from their invaders and integrate them into their own genome.  This allows them to be 
prepared with a defense system that can cleavage another attack of the invading phage.  The new 
segment of DNA, which is usually 20 to 50 nucleotides long, is incorporated into the gene of the 
bacteria leaving its original DNA spaced in between the new segments and with a similar length.  
This pattern of incorporating and spacing is what gave this method its name.20 
                                                          
16 See National Academy, Human Genome Editing, 63. 
17 See ibid., 64. 
18 See ibid., 2. 
19 See ibid., 2. 
20 See Kursad Turksen, ed., Genome Editing (Switzerland: Springer, 2016), 6. 
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The actual method of editing with CRISPR/Cas9 involves that the nuclease is combined 
with a strand of RNA containing the desired sequence of A, C, G, T targeted for removal.  This 
RNA is created in the laboratory for this specific purpose and it leads the CRISPR/Cas9 to the 
target in the DNA.  Due to this role, it is called guide RNA (gRNA).  Once it reaches the desired 
sequence it cuts off that segment of DNA.  Immediately it replaces it with a new segment of 
RNA, with new coding information.    Figure 3 is a simple illustration of how does 
CRISPR/Cas9 interact with the DNA. 
 
Advantages of CRISPR-Cas9 compared with other genetic editing methods  
When comparing it with other methods of genome editing, all the scientific journals 
recognize that at the present moment CRISPR/Cas9 is the best option.  “The CRISPR/Cas9 
system is simpler, faster, and cheaper relative to earlier methods and can be highly efficient.”21  
With the other techniques a new protein has to be created or engineered to match for each 
genome.  With this method the protein that is always used is Cas9.  What needs to be created is 
the guide RNA (gRNA), and that usually takes only a few days, it is simple to do and can match 
any sequence of nucleotides.  In comparison with other methods of editing, the preparation 
process went from $5,000 USD for a previous method called ZFNs (zinc finger nuclease) to $30 
USD for Cas9/gRNA.22  Clearly a dramatic reduction in cost!  The production of a variety of 
gRNA in contrast to a variety of proteins is the key difference between these methods. 
 
                                                          
21 National Academy, Human Genome Editing, 65. 




Figure 3.  Mechanism of CRISPR/Cas9.23 
Some of the advantages of CRISPR/Cas9 highlighted by the scientific world can be 
summarized as:  this endonuclease is constant and does not need to be reengineered for each 
target; it can target multiple sites simultaneously; it has been used in vitro and in vivo (other 
methods of genome editing can only be applied in vitro); it has a great ability to cleave the DNA 
                                                          
23 Mechanism of CRISPR/Cas 9, last accessed October 28, 2019, 
https://www.ncbi.nlm.nih.gov/books/NBK464635/figure/gen_edit.F2/?report=objectonly.  Copyright Notice:  All 
Assay Guidance Manual content, except where otherwise noted, is licensed under a Creative Commons Attribution-
NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0), which permits copying, distribution, 




in spite of being an external agent (epigenetic).24  In other words, compared with the previous 
discovered techniques, CRISPR-Cas9 has simple reprogramming, a highly efficient and multiple 
capability.25  This method can be applied to multiple genes at the same time. 
 
Research and experimentation 
For several years and with great success, gene editing experimentation has been applied 
on yeast, zebrafish, mice, rats, rabbits, monkeys, and a variety of crops and livestock.  Overall 
the purpose was to make these crops and livestock resistant to certain pathogens, to protect them 
from diseases and parasites and also to increase their productivity.  The advantage highlighted is 
that it would eliminate the need of using pesticides and other chemicals which could cause 
secondary impacts on the environment.26  During the last few decades some experimentation 
with livestock has been done with the special interest of making the proper modifications that 
would create the right match for xenotransplantation, i.e. the transplantation of organs or tissues 
between different species, with a special interest in obtaining healthy anatomic material from an 
animal for a human being.  Moreover, other attempts to modify certain tissues in these animals 
have been done so that they can become models for trials of research on human diseases.27  
More recently, basic research has taken place on somatic cells, such as human skin, liver 
and heart.28  In order to achieve a recognizable impact, labs have been using HeLa cells and mice 
as critical research subjects for observation of the effectiveness of genome editing.29  Especially 
                                                          
24 See Turksen, Genome Editing, 8. 
25 See ibid., 2. 
26 See Isabelle Duroux-Richard, Carine Giovabbabgeli and Florence Apparailly,  “CRISPR-Cas9: A revolution in 
genome editing in rheumatic diseases,” Joint Bone Spine 84 (2017): 3. 
27 See Turksen, Genome Editing, 16. 
28 See National Academy, Human Genome Editing, 3. 
29 See Parrington, Redesigning Life, 94-95. 
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in vitro, most cells have a limited reproduction timeline before they die.  The HeLa cells, which 
were ‘discovered’ in 1941, have been dividing and multiplying themselves since then.30   
Based on the published research, when it comes to experimentation with human cells and 
illnesses, some researchers focused on embryonic stem cells.  For other researchers, the goal, as 
in the case of other living creatures especially the mice, would be to apply the editing method to 
the full grown animal.  Ultimately, the goal of the research is to benefit adult human beings, to 
edit their genes.31 
Even though clinical trials with humans are not yet allowed, in April 2015 it has been 
announced an experimentation with human embryos.  Junjiu Huang was the leader of a team at 
Sun Yat-Sen University in China that tried to correct a blood disorder called β-thalassaemia.  The 
research was not considered fully successful due to a low efficiency and accuracy and because of 
secondary effects.  Other scientists believe that the unsuccessful outcome was caused by not 
using the best CRISPR/Cas9 technology.32 
In the United States, scientists are already using CRISPR/Cas9 with human genes: 
On August 2, 2017, Shoukhrat Mitalipov’s research lab at Oregon Health and 
Science University in Portland published their results on the editing of DNA in 
human embryos, the first known attempt in the United States.  The Mitalipov lab 
set out to correct the mutated MYBPC3 gene in human embryos, which often 
causes a condition called hypertrophic cardiomyopathy, characterized by 
abnormally thick heart muscles.  The authors stated that this condition is “the 
commonest cause of sudden death in otherwise healthy young athletes.”33 
 
Another attempt with human trials took place in China in November 2018.  Dr. He 
Jiankui announced in Hong Kong,  
 
                                                          
30 In her book, The Immortal Life of Henrietta Lacks, Rebecca Skloot explains the ‘ongoing life’ of the cancer cells 
named HeLa. 
31 See Parrington, Redesigning Life, 99. 
32 See ibid., 107. 
33 James Mary Ritch, O.P., “Human Gene Editing: A Century of Tears to a Century of Fears?,” Dominicana (August 




that he had recruited several couples in which the man had H.I.V. and then used in 
vitro fertilization to create human embryos that were resistant to the virus that 
causes AIDS. He said he did it by directing Crispr-Cas9 to deliberately disable a 
gene, known as CCR₅, that is used to make a protein H.I.V. needs to enter cells.  
Dr. He said the experiment worked for a couple whose twin girls were born in 
November.  He said there were no adverse effects on other genes.34   
 
This news provoked mixed reactions within the scientific circles in China and beyond. 
Before actually moving forward to human trials the scientific community, but also the 
general population, should be made aware and educated in this matter.  This education is 
essential, because there is already a shift in support from the general community even without 
necessarily knowing and understanding the benefits and adverse effects behind this editing 
technique.  Possible future clinical applications should not depend on human consensus, 
especially if it is not well informed.35 
The first challenge for researchers is trying to identify if (and which) diseases can 
actually be approached and healed with genetic editing.  One of the concerns is that a gene 
causing a disease may handle several traits of the person, therefore changing or editing the gene 
may have other impacts beyond the desired healing.  Based on the experimentation with mice, 
CRISPR/Cas9 may be able to edit the genetic mutations causing muscular dystrophy.  The trials 
focused on cardiac and skeleton muscles of the mice.  The results did not indicate a complete 




                                                          
34 Gina Kolata, Sui-Lee Wee, and PamBelluck, “Chinese Scientist Claims to Use Crispr to Make First Genetically 
Edited Babies,” The New York Times, November 26, 2018, https://www.nytimes.com/2018/11/26/health/gene-
editing-babies-china.html. 
35 See Sandy S.C. Hung et al., “Genome engineering in ophthalmology: Application of CRISPR/Cas9 to the 
treatment of eye disease,” Progress in Retinal and Eye Research 53 (2016), 15. 
36 See David A. Prentice, “Science,” The National Catholic Bioethics Quarterly 18, no. 2 (Summer 2018), 332. 
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Which human somatic illnesses could be treated? 
Somatic cells are the cells found in the body except for the reproductive cells (egg and 
sperm) and their precursors.37  Figure 4 shows the 22 pairs of somatic chromosomes and the one 
pair of sex chromosomes. 
 
Figure 4.  Human chromosomes.38 
Which somatic illnesses have a genetic cause?  Among the illnesses caused by a mutation 
in the aminoacid sequence of the person are sickle cell disease, hemophilia A & B, some forms 
of Duchenne muscular dystrophy (as mentioned earlier, it has already been tried with mice), 
Wiskott-Aldrich syndrome, and cystic fibrosis.39  At the same time, successful trials have taken 
place by genetically inactivating viral infections that attack the body.  All of these illnesses are 
the result of some form of genetic mutation within the carrier, that can be either inherited or not.  
Therefore, it seems that this method of gene editing could not be used to heal what are 
considered non-genetic illnesses such as heart diseases and diabetes, because their causes go 
beyond the genetic issues.   
                                                          
37 See National Academy, Human Genome Editing, 5. 
38 Human chromosomes, U.S. National Library of Medicine, last accessed October 28, 2019, 
https://ghr.nlm.nih.gov/primer/basics/howmanychromosomes. 
39 See Turksen, Genome Editing, 16. 
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However, genome editing could be clinically applied to these complex somatic illnesses 
by removing the affected cells from the body, performing the genetic editing and then returning 
these cells to the body.  Since this procedure would take place outside of the body (ex vivo), it 
would be easier for the lab personnel to confirm the success or failure of the editing.  It could 
also be possible to apply genetic editing in vivo but it would involve more technical challenges.40  
Right now it is all theory when it comes to clinical applications in human beings.  Another 
important factor that needs to be determined is whether there is an ideal stage or age of the 
patient to make this procedure successful; or if there is threshold beyond which it would be too 
late to proceed.  Maybe due to the lack of human trials it is not possible to answer those 
questions at this time. 
The less complex is the mutation, the more effective is the editing process.  One human 
related condition, that could be appropriate for research, concerns the genes responsible of 
inflammations and other bone issues causing rheumatic disease.  As far as researches know, 
these diseases are the results of single mutations and therefore a better target for CRISPR/Cas9.41  
Inherited retinal diseases could be another first attempt for using CRISPR in human trials.  The 
eye provides an easy access and a compartmentalized anatomy that increases the success of the 
editing.  Some scientists recommend the eye as the appropriate first clinical trials because human 
editing can take place in vivo, ex vivo, or in vitro; and it is focused on ‘adult’ patients.  The 
downfall remains the same as with all other implementations:  there is a percent of the DNA that 
will restore itself and not necessarily be modified to the desired genetic sequence.42  In theory, 
there is no way of achieving a 100% correction and there could be maybe as much as 40% that 
                                                          
40 See National Academy, Human Genome Editing, 5. 
41 See Duroux-Richard et al., “CRISPR-Cas9,” 3. 
42 See Hung et al., “Genome engineering in ophthalmology,” 11. 
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will recombine on its own.  Therefore the practical option would be to edit as many genes as 
possible to be able to generate the desired change.43 
In order to increase the trust that this method could work and therefore human clinical 
experimentation can begin, there are a few hurdles in the procedure that should be addressed.  
First, there should be a reduction in NHEJ, which is the nonhomologous end joining, when the 
DNA reconnects itself.  Second, it is necessary to enhance the effectiveness of the HDR, the 
homology-directed repair, which is the desired new/healthy sequence.  Third, improved vectors 
should direct the CRISPR/Cas9 to the right part of the body and within the cells.44 
 
Ex vivo versus in vivo editing 
 In the everyday work in the world of science, genes carrying only certain diseases can be 
effectively edited.  Some of the cells containing the mutated genes can be removed from the 
body and edited in a laboratory–ex vivo; while other cells would have to remain in the body–in 
vivo.  Ex vivo editing could be applied to genes contained blood and skin cells and in some 
neurons; in vivo editing could focus on muscles and liver cells and neurons from the central 
nervous system.45  In either scenario, the chosen cells must have stem cell-like characteristics, 
which implies that they can continue to reproduce themselves.  When the targeted cells are 
removed from the body, their genes are edited, and they can be checked several times before they 
are transplanted back to the body.  The challenge in the lab is to isolate the desired cells and 
being able to grow them outside the body.  When in vivo, the greatest challenge is improving the 
targeting, so that no other genes and tissues are being affected.46  Therefore the key advantages 
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44 See ibid., 16. 
45 See National Academy, Human Genome Editing, 96. 
46 See ibid., 96. 
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of ex vivo are that no other cells are being impacted by the editing process, the genes returned to 
the body can be selected, and their editing confirmed.47  
The risks of ex vivo could be “apoptosis (cell death), differentiation (changing cell type), 
cell senescence (aging) and replicative arrest (cells stop dividing)”.48  Besides those risks there 
are also the challenges of guaranteeing that there are enough healthy genes to be transplanted 
back to the body and that they are mature or stable enough.  If that is not the case, the 
transplantation could cause new mutations. 
The main challenge with in vivo is controlling the editing tools.  What will they impact 
once they are inside the cell?  Researchers are still working in finding ways to limit the editing to 
the desired targets, especially to avoid affecting the germ cells.49  Based on research made on the 
human genome, the researchers know that in cells there is already a certain level of natural 
mutations happening that do not cause a major impact on bodily functions.  These mutations are 
caused by radiation and chemicals in the environment.  The body copes with these mutations.  
Recognizing that it is impossible to control 100 percent the impact of the editing tools, a goal is 
that the off-target mutations are at a lower rate than the natural mutations the body is already 
facing.50  It is important to acknowledge than in the preclinical research the ratio between on-
target versus off-target is what will determine the efficiency of the method.51 
 
The role of government agencies 
When it comes to animals and plants the USDA (United States Department of 
Agriculture) regulates the experiments and the actual implementation of the final results.  
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Genetic editing has been placed under the umbrella of genetic therapies and it is the US Food 
and Drug Administration (FDA) that approves or not the clinical trials.  Two are the main 
concerns for the research.  First, there needs to be clarity of the source of the tissue that is to be 
used for experimentation.  There is a difference if the tissue is the ‘leftover of a surgery’, that is, 
tissue that would be discarded and therefore not identifiable; in contrast with tissue taken from 
the person with the purpose of being studied, making that person an actual subject of research.  
Once the person is a subject, there needs to be an informed consent, because the person needs to 
be fully aware of what is the purpose of the research and its possible outcomes.  The researchers 
should always obtain the permission of the person to use their biological material.52  Second, it 
needs to be clear whether the donors are being paid; because if they are, it is necessary to 
confirm the absence of conflicts, interests, and abuses.  Third, there is also a concern for the 
safety of the workers involved in the research.  As with any other work dealing with 
biochemistry, it is important to take all the proper precautions necessary in regards to the 
workers being exposed to and handling the different products and byproducts of the research. 
As with gene therapies, the final authority of approval is the FDA.  This government 
agency relies on the support of various committees and boards (the RAC, IRBs, IBCs, among 
many others).  The Recombinant DNA Advisory Committee (RAC) oversees the potential use or 
misuse of recombinant DNA.  In particular: “The Recombinant DNA Advisory Committee is a 
federal advisory committee that provides recommendations to the NIH Director related to basic 
and clinical research involving recombinant or synthetic nucleic acid molecules.  RAC 
proceedings and reports are posted to the OSP Website to enhance their accessibility to the 
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scientific and lay public.”53  This committee is formed by scientists and clinicians, ethicists and 
theologians, but not government employees.  One of its strengths and goals is to make the 
information accessible to the public, which includes the broader scientific world, but also the 
common folk.  By doing the latter, the purpose is to create a level of trust by educating and 
informing the citizens.   
The individual research labs should have an institutional review board (IRB), which 
observes the recruitment process of the subjects for the clinical study.  As mentioned before it is 
necessary that the subject is well informed and educated on the research, and has full capacity 
and freedom to consent.   
The labs should also have an institutional biosafety committee (IBC) to guarantee the 
safe conditions of what is done, who is doing it, and any possible risk.54  Examples of public 
venues of information can be found in the Office of Science Policy website and the 
ClinicalTrials.gov website.  Once the FDA approves the clinical trials and if the time will come 
to approve the clinical use of genetic editing, this agency will continue to monitor it in case some 
delayed negative effects appear.55 
In December 2016, the 21st Century Cures Act was approved by Congress to allow 
genome editing to enter into a fast track if it qualifies as a ‘regenerative-medicine therapy’.  The 
expectation is to “facilitate the development, review, and approval of genetically targeted drugs 
and variant protein targeted drugs to address an unmet medical need in one or more patient 
subgroups, including subgroups of patients with different mutations of a gene, with respect to 
                                                          
53 At the National Institutes of Health, the Office of Science Policy describes itself as: “The NIH Office of Science 
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rare diseases or conditions that are serious or life-threatening”.56  If researchers can prove that 
they are doing this, the FDA could grant them the permission they need to begin the clinical 
trials.57 
In the U.S., genome editing research is framed by some general principles or guidelines 
established by the National Commission for the Protection of Human Subjects in Biomedical and 
Behavioral Research.  First, its intention and purpose should be promoting well-being, which 
includes minimizing any risk in early clinical trials and treatments.58  Second, to be transparent 
with the information to government agencies, other scientists and the public in general, 
especially those involved in trials.  Third, having due care for the patients by implementing 
methods of editing once there is enough information to be sure that it is safe to apply editing to 
humans.  The fourth principle is responsible science, which implies the highest standards of 
research.59  The fifth principle is critical within and beyond the laboratory, respect for persons.  
Respect implies always being aware that the person treated has dignity; and that dignity is both 
individual and collective.  Sometimes it is easy for an individual to be lost or unnoticed, 
becoming then a victim or guinea pig of the scientists; even at times painted as a hero or a 
sacrificial lamb on behalf of the good of the entire humanity.  Also it is important to uphold the 
dignity of the different groups or categories of people: the sick, the poor, the mentally 
challenged, the prisoners, just to mention a few of those who have already been used and abused.  
Sixth is the principle of fairness, which “requires that like cases be treated alike, and that risks 
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and benefits be equitably distributed.”60  Finally, there needs to be transnational cooperation.  In 
an ideal world, these principles and benefits should apply to anyone anywhere in this planet. 
The Universal Declaration of Bioethics and Human Rights reminds the scientific world 
that “a person’s identity includes biological, psychological, social, cultural and spiritual 
dimensions.”61  Unfortunately, our history has proven that many unethical experiments have 
taken place on indigenous communities and vulnerable people.  That is why the developing 
countries should share the benefits of the medical, scientific and technological research (Art. 2.f).  
Moreover, the dignity of the person has priority over the interests of science (Art. 3.2).  Finally, 
the subject should be a beneficiary of the research but  
(r)esearch which does not have potential direct health benefit should only be 
undertaken by way of exception, with the utmost restraint, exposing the person 
only to a minimal risk and minimal burden and, if the research is expected to 
contribute to the health benefit of other persons in the same category, subject to 
the conditions prescribed by law and compatible with the protection of the 
individual’s human rights.  (Art. 7.b).  
  
If the research is conducted by an out of State institution, both the host country and the country 
of origin should review all the procedures to guarantee the well being of all the subjects involved 
in the clinical trials (Art. 21).  This implies also that all States involved should guarantee that the 
illicit traffic of genetic-related materials is not taking place. 
The person involved in clinical trials deserves the highest level of protection and care.  
That is why providing the person with as much information as possible is necessary in order for 
him or her to give their consent.  The US Department of Health and Human Services (HHS) has 
                                                          
60 National Academy, Human Genome Editing, 34. 




regulations for obtaining the subject’s consent.  These can be found in the Federal Policy for the 
Protection of Human Subjects as it appears in the January 19, 2017 edition:62 
Basic elements of informed consent (…): 
    (1) A statement that the study involves research, an explanation of the purposes 
of the research and the expected duration of the subject's participation, a 
description of the procedures to be followed, and identification of any procedures 
that are experimental;  
    (2) A description of any reasonably foreseeable risks or discomforts to the 
subject; 
    (3) A description of any benefits to the subject or to others that may reasonably 
be expected from the research; 
    (4) A disclosure of appropriate alternative procedures or courses of treatment, if 
any, that might be advantageous to the subject; 
    (5) A statement describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained; 
    (6) For research involving more than minimal risk, an explanation as to 
whether any compensation and an explanation as to whether any medical 
treatments are available if injury occurs and, if so, what they consist of, or where 
further information may be obtained; 
    (7) An explanation of whom to contact for answers to pertinent questions about 
the research and research subjects’ rights, and whom to contact in the event of a 
research-related injury to the subject; 
    (8) A statement that participation is voluntary, refusal to participate will 
involve no penalty or loss of benefits…  
     
Additional elements of informed consent: 
    (3) Any additional costs to the subject that may result from participation in the 
research; 
    (5) A statement that significant new findings developed during the course of the 
research that may relate to the subject's willingness to continue participation will 
be provided to the subject; 
    (7) A statement that the subject's biospecimens (even if identifiers are removed) 
may be used for commercial profit and whether the subject will or will not share 
in this commercial profit; 
    (9) For research involving biospecimens, whether the research will (if known) 
or might include whole genome sequencing (i.e., sequencing of a human germline 





                                                          




Human beings have been blessed with the ability to develop and create techniques that 
could heal the body.  Clearly in the case of somatic illnesses, CRISPR/Cas9 could provide an 
opportunity to correct a mutation in order to overcome an illness that the person already has or 
could develop later in life. 
The sources from which the Cas9 is produced do not violate the dignity of the human 
being in any of the stages of development.  As a matter of fact, they do not abuse or misuse any 
other animal and natural resources.  Creating Cas9 does not produce any byproducts that should 
be of concern for present and future generations.  Embryos are not being harvested or frozen for 
this purpose. 
The experiment of Junjiu Huang’s team was with a defected human embryo, that 
according to them would have been discarded anyways.63  This utilitarian approach to a human 
embryo, even if it carries an illness or defect, is definitely an area of concern for many ethicists 
and moral theologians.  Scientists are divided among themselves when it comes to using human 
embryos.  Most will agree that the moratorium on research with humans should be kept until 
confirming that genome editing is truly safe.  Some scientists will be content once the level of 
safety is reached and they receive the green light for human experimentation; others are hesitant 
of tampering human genes and would rather stay focused on other animals and crops.64  The use 
of embryos in any way, but especially research, is far from being resolved between ethicists and 
scientists. 
There is no doubt that the cost involved with CRISPR/Cas9 is dramatically less than 
previous techniques.  To the fact of being financially affordable and based on the 
                                                          
63 See Parrington, Redesigning Life, 107. 
64 See ibid., 107. 
30 
 
experimentation done on other living creatures, scientist are trying to prove that there is also the 
benefit of no secondary effects to the recipient.  That being the case, this could be a great healing 
method.  It is not fully clear if the population in the developing countries and even those who are 
non-insured and underinsured in the developed countries could afford it.  That remains to be seen 
until the FDA approves these techniques.  Once this editing will be available, will it be a 
treatment for the financially privileged?  If that is the case then the health conditions of those in a 
middle class and/or the wealthy class will enjoy better health conditions.  On the contrary, the 
financially distressed members of society, who are already at a lower level of access to health 
and care, would become even more marginalized.  This dynamic would foster an increased level 
of poverty for individuals and certain communities. 
The Universal Declaration of Bioethics and Human Rights in its Article 12 calls for the 
due respect given to cultural diversity and pluralism.  It is necessary to recognize the difference 
between culture and the persons themselves in that statement.  Some people understand pluralism 
as a way to justify the need for socioeconomic diversity, and they interpret that it is an advantage 
for society to have distinct groups.  In other words, according to such views society needs the 
gap between groups to keep the status quo: wealthy and poor, healthy and sick, strong and weak. 
 
Virtues needed in clinical research 
For decades one of the most common practices in clinical trials was to offer some 
patients / candidates the new medicine or treatment and to others a placebo.  It was considered 
good scientific practice that the research team would not know which ones received the medicine 
and which ones did not.  As time went by, the moral issue in question became the actual lack of 
treatment for those with the placebo.  They were not being cared for.  Even though there are 
31 
 
strong attempts to correct this practice, it still depends on the notion of the sacrifice of a few for 
the greater good.65 
Another reality is that the people in the developing world are not focused on genetic 
illnesses.  They have greater concerns like healing people with AIDS and malaria, or at least 
reduce these illnesses from spreading.  In the list of diseases and treatments, genetic editing is on 
the agenda of those who are already enjoying better health and more sophisticated healthcare 
systems, those living in the developed world.  They are the ones researching and investing 
resources; but also reaping the benefits.66  Benefits for the people receiving the treatments and, 
like with the rest of the pharmaceutical industry and technology, for the private companies 
involved in any genetic enterprise.67  They are for profit. 
To address this issue Neil Messer, in his book Respecting Life: Theology and Bioethics, 
uses William May’s virtue ethics68 to argue in favor of applying some essential virtues to both 
clinical medicine and clinical research; virtues which could so easily seen as necessary in genetic 
editing.  He highlights the virtue of benevolence, that like all other virtues aims to promote the 
good of the person.  Any attempt to modify genes should be done first and foremost for the good 
of the individual.  This notion of the good of the individual can easily be distorted when ‘good’ 
is too subjective - an issue found in the developed countries since the end of the twentieth 
century.  The overemphasis on the individuals’ rights, desires and happiness has created a 
personalized concept of what is good.  Prudence is needed in order to discern what it is really 
the best decision for the whole of the patient.  Fidelity is recognizing that the interest of the 
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patient goes before the benefits and interests of the doctor/therapist and in many ways also 
before the benefits of the rest of society.  This aims at avoiding a utilitarian approach of the 
person.  Messer reflects also on the virtue of public spiritedness, which refers to collaborating 
with other fields and layers of society in order to achieve the desired good:  relieve the person 
from illness and suffering.69  Clearly, there is also a need for the virtue of truthfulness, making 
sure that the researchers provide an honest report of their findings to the rest of the scientific 
world but also to that individual patient may become the subject of a trial.70  As an overall 
umbrella for these virtues Messer insists that the theological virtue of charity is needed.  By 
doing so it guarantees that the reason for pursuing research is not only for fame and money, but 
truly love for the neighbor.71  The goal of practicing these virtues is to keep the research humane 
and dignified; this is quite a challenge when, for large transnational corporations, fame and 
money among others are also relevant factors. 
It is important to reflect on how financial resources are allocated to genetic editing.  At 
this point it is not possible to define carefully the costs for the patient or the health insurance 
because of the lack of approval by the FDA.  In spite of this, it could be presumed that in theory 
some financial advantages may be attached to edit a mutation that is causing an illness.  
Depending on the illness, the amount of drugs needed, the treatments that are required and the 
care providers involved in order to treat and, hopefully, heal a person, could be very expensive 
both for the individual (or the family) and the health insurance (or taxpayers).  If CRISPR/Cas9 
could become an accurate and efficient technology, in theory it should be a one-time expense.  
Would this then be a more prudent and wise approach of using the research funds available?   
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Moreover, most drug companies tend to focus on research to overcome widespread 
illnesses.  There is a greater need and a higher demand to search for the best healing method; and 
at the same time this focus spreads the cost of the research investments, drug production and 
marketing.  Hopefully this worldwide approach is a key motivator.  However, the reality is that 
some diseases get more attention and resources than others, especially when treating people in 
the developed world.  When there are fewer cases of a certain disease, the investment of human 
and financial resources changes.  Usually research requires an extended length of time, therefore 
increasing its cost.  Especially if the person sick is a child, the parents and most probably 
everyone who has met the child with this rare genetic illness would want to see some form of 
treatment and healing as soon as possible.  Could genetic editing, especially with CRISPR/Cas9, 
provide the flexibility needed to address some of those rare conditions without having to engage 
in a decade of drug creation, trials and approvals?72  
James Keenan, SJ, in his vast work in virtue ethics, recommends his own list of cardinal 
virtues.  By considering how genetic diseases affect human dynamics, these virtues can be 
examined apart from the previous virtues.  Keenan proposes justice (for the broad relations and 
interactions), fidelity (for particular relationship) and self-care (the preservation and care of the 
individual), to which he adds the virtue of prudence that brings harmony and balance between 
the other three.73  Virtue ethics highlights the importance and the need of each person to become 
better, to be an improved version of themselves.  It takes under consideration the persons’ gifts 
and abilities, but also their limitations.  For anyone involved in scientific research, the virtue of 
justice is essential, since it inspires the actions taking place in the laboratories and aims at 
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promoting equality.  As Keenan says, “virtues aim for equality in the name of justice.”74  This 
equality is deeper than everyone getting the same amount or having the same opportunity, it 
inspires a greater respect for humanity.  “Virtue ethicists therefore remind geneticists that their 
work is not a manipulation of some object-out-there but inevitably is a manipulation of our very 
selves.”75  Whatever is done in the research labs and with human trials is not only affecting my 
child, “because they are our progeny, we are affecting our human race.”76  The impact of healing 
somatic illnesses, germline editing (Chapter Two), and enhancements (Chapter Three) have on 
the human race, is why it is critical the involvement of everyone “in any dialogue on genetics 
because of their vested (self-) interest.”77  
The virtue of justice could be placed in tension with the other two virtues of fidelity and 
self-care, when the person desiring and approving genetic editing is deeply concerned for the 
well being and for the healing of their loved ones.  As in many other health scenarios with ethical 
dilemmas, usually those pleading for the approval of the government, for the public to vote in 
favor of specific funding for research projects are people who have someone they love suffering 
or facing an illness.  No outsider can question their love, not even when it is the same person 
pleading for herself as she longs for a ‘normal’ life.  Love or fidelity is not what is being 
questioned here.  What needs to be evaluated in this case is the actual practice of human genetic 
editing.  The virtue of prudence can assist in placing the motivations, the methods and goods 
obtained on the balance, in order to compare the benefits for the entire humanity with the 
benefits for an individual.  
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When research is not properly regulated by government agencies (acknowledging that 
these agencies are staffed with people who have their own limitations and biases), some entities 
sponsored by government and others operating completely with private funding, may take 
advantage of people in distress and with the desire to be healed or to have a loved one healed.  
As mentioned earlier, some researchers have already proceeded with clinical trials, even though 
there are still reservations with the methods and possible outcomes.  Clearly it is a challenge to 
control these ‘opportunities to be healed’ in such an early stage of development, when they are 
being offered in a different country due to their more relaxed regulations.78 
 
Teachings of the Magisterium 
When approaching the possibility of clinical trials with embryos and fetus, two main 
concerns are: how to apply the previous rules of consent, and the difficulty of foreseeing the 
actual impact on the child to be born.  The latter can only be confirmed after the birth, when 
nothing can be done to change it.79  The overall approach with genetic editing, as with any other 
treatment and medication, is to determine the risk/benefit balance.  When studying this balance, 
researchers, government agencies and society in general should always make sure that the 
benefits are greater than the risks. 
The Congregation for the Doctrine of the Faith, in Dignitas personae: On Certain 
Bioethical Questions, speaking on behalf of the Church’s Magisterium and in agreement to the 
previous arguments, provides the following statement:   
For a moral evaluation the following distinctions need to be kept in mind.  
Procedures used on somatic cells for strictly therapeutic purposes are in principle 
morally licit.  Such actions seek to restore the normal genetic configuration of the 
patient or to counter damage caused by genetic anomalies or those related to other 
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pathologies.  Given that gene therapy can involve significant risks for the patient, 
the ethical principle must be observed according to which, in order to proceed to a 
therapeutic intervention, it is necessary to establish beforehand that the person 
being treated will not be exposed to risks to his health or physical integrity which 
are excessive or disproportionate to the gravity of the pathology for which a cure 
is sought.  The informed consent of the patient or his legitimate representative is 
also required.80  
 
The Congregation is not condemning or disapproving the possibilities of genetic editing.  
It reminds us that procedures on somatic cells meant to heal a person are morally licit.  One key 
concern in Dignitas personae is that the consequences to the subject should not be “excessive or 
disproportionate” in comparison with the actual illness. 
That being said about somatic illnesses, the next question is what about the genetic 
editing that is not limited to changing the body of the subject in the clinical trial, but also the 
future children and maybe grandchildren of this person?  And that leads us to the next chapter.   
  
                                                          










Genetic editing that impacts the germline cells 
 
In the previous chapter, we indicated that CRISPR/Cas9 was used to modify and correct 
the mutations in the eye, the skin, the blood cells and the muscles.  All of these mutations 
concern the somatic cells of the body.  Another group of cells present in the body, but in a lesser 
quantity, are the germline cells.  These cells are responsible for procreation, for the beginning of 
new life.   
 
Figure 5.  Germline cells.81 
                                                          




The actual procedure or technology for genetic editing would be the same for both the 
somatic and the germline cells.  The main distinction between editing germline cells and somatic 
cells is that the potential benefits and the potential harms caused by modifying the gene could be 
inherited and passed down in the first case, but not in the second.  Children and grandchildren 
will become bearers of the modification.  Due to a lack of human trials and the limited 
experimentation and results with other animals, it has been impossible to determine the extent of 
these inherited benefits or harms.   
One of the reasons that make this research appealing is that it could provide the parents 
an opportunity to have a healthy child that shares their genetic makeup.  So far, if parents with a 
heritable genetic illness want to have a healthy child, their main and only guaranteed option of 
having one is to adopt a baby.  In the more recent decades, parents have been relying on the 
services provided by sperm and egg banks.  In this way they could find a healthy sperm or egg 
donor in order to circumvent the unhealthy parental inheritance.  The dilemma is that in both 
cases, the adoption or the donor, the couple can say that neither child is ‘fully our child’.  As 
time goes by and more options are available to increase the opportunities of having a newborn 
with the parents’ sperm and egg, the parents are more inclined to desire and explore them.   
If all the illnesses that are caused by an inherited genetic mutation were combined, they 
would add up to maybe 5 to 7 % of the population.  Therefore, each individual illness occurs at a 
lower percent.  The incidence or the amount of patients with the illness becomes the key factor to 
determine the priority or the focus of the researchers.  These lower numbers of cases impact the 
cost of the treatments and the research needed to promote healing, causing them to be more 
expensive per capita.82   
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One critical question that needs to be answered is: in real life and not just in theory, does 
the genetic edited material pass on to the descendants?  Among the many experimental 
researches, one was done with rats.  Some testicular stem cells were extracted from the rat, 
genetically edited with CRISPR/Cas9 and then transferred back to the rat’s testicles.  Before 
returning them, the stem cells left in the testicles were destroyed with chemotherapy.  Once the 
rat mated, the offspring showed the genetic changes done by the researchers.83  Therefore, based 
on this trial this type of gene editing does carry the modification down the line!  Would the same 
thing happen with humans? 
Some possibilities of mutations that could be addressed and have already appealed to 
scientists are BRCA1/BRCA2 and DMD.  The BRCAs are genes related to the development of 
tumors in the breasts and the ovaries, causing cancer.84  During the last decade, when women 
found out that they might have these mutated genes, one of the preventive measures was to 
remove the ‘healthy’ organ, even before experiencing any physical sign of the cancer.  One of 
the most popular cases of this early approach to the illness, which received plenty of coverage by 
the media, was the case of the actress Angelina Jolie.  In 2013 she had a mastectomy as a 
response to the results of her genetic testing, which showed positive and thus indicate the 
potential to develop breast cancer.85  In cases like this one, could CRISPR/Cas9 provide the 
option of editing the gene carrying the mutation and thus avoid the elimination of the actual 
organ(s) and reducing the risk of developing the possible disease? 
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If Duchenne muscular dystrophy (DMD)86 were to be treated exclusively with somatic 
genetic editing, the most that could happen would be to reduce the symptoms of the illness 
considerably, but the person would not be healed completely since many tissues are being 
affected by this mutation.  It seems that if DMD were to be treated using germline editing, the 
chances of eliminating the illness would be greater.  As a side note, there could be as many as a 
third of the cases of DMD caused by new mutations that would not be recognized during the 
screening process.87 
Our society is overwhelmed with loved ones who suffer from Alzheimer’s disease.  The 
risk of developing this illness is increased by mutations in the gene APOE4.  In theory, if this 
gene could be modified, that would avoid or reduce the risk of Alzheimer.  But in the 
microcosms of genetics, things are never simple and clear cut!  Researchers have found that 
APOE4 appears to protect the liver from damages caused by hepatitis C.  This raises a new 
dilemma.  Would it be more advantageous for the body to keep this defense mechanism or to 
eliminate it?88 
When and how to do the editing?  One of the procedure options is to make the editing of 
the genes in the embryo.  The problem could be that not all the cells become edited.  Obviously, 
due to the size of the embryo and in order to avoid harming it, only a few cells should be 
removed for verification.89  This is why clinicians would prefer to edit the gene within in vitro 
fertilization (IVF),90 which brings us to the next section. 
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 Before any of these procedures with CRISPR/Cas9 reaches clinical trials with humans, it 
has and is being tested on plants and animals.  One possibility of genome editing that scientists 
would want is to observe if the germline modification works effectively through multiple 
generations, particularly in mosquitoes carrying the malaria parasite.  If scientists could mutate 
the gene in the mosquito to make it resistant to the parasite instead of being a carrier, and if these 
mosquitoes continue to mate and procreate genetically modified mosquitoes, then they may have 
found a way to restrain the spreading of this illness.  Research has shown that the modification is 
inherited by 99.5 of the offspring.91  The concern at hand is what would be the environmental 
long term effect of having this vast number of genetically modified mosquitoes reproducing 
themselves. 
 
Ethical issues with the secondary methods 
Working with the gametes (egg or sperm) or the gametes precursors seems to guarantee 
that the actual mutation is being corrected before fertilization and then transferred into the uterus.  
These procedures take place outside the body and therefore they are called in vitro fertilization 
(IVF).  It is necessary at this point to remind the reader that the teachings of the Catholic Church 
do not condone IVF, and there are plenty of documents discussing the morality behind it.  (Since 
this research paper does not enter into the ethical discussion regarding IVF, if you want to learn 
more about the Catholic teachings available, a starting point would be the Catechism of Catholic 
Church.)  To engage in that debate (which is important) would distract from focusing on genetic 
editing.  For the sake of discussing genetic modification, it is necessary to recognize that IVF is 
presently practiced by many couples and it is used in many laboratories and in research. 
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The Catholic Church applies the same teachings and expectations in regards to any work 
done with eggs and sperm to zygotes and embryos.  The experimentations and procedures that 
take place at these stages of human development allow both scientists and families to pick and 
choose which embryos they want to keep and which ones they want to discard.  Some embryos 
are discarded before implantation while others are discarded later in the development having, in 
most cases, to induce an abortion.  In the case of either option, the termination of an embryo has 
generated a passionate ethical debate that is not part of this research.  Although it is necessary to 
remember that all these debates are necessary, and that the Catholic Church upholds the sanctity 
of life from the moment of conception.  Therefore, the official teaching on this matter is that all 
fertilized eggs, let it be in the womb or in a freezer, are human cells. 
Hence, the official teaching of the Catholic Church has issues with the previous 
procedures and that unfortunately they are a common scientific practice.  To these practices a 
new layer has been added: germline editing. 
 
Ethical issues with germline editing 
When posing the question of whether it is wise to proceed with germline genetic editing, 
there has to be an honest analysis of the balance between the benefits for the individual and the 
benefits for society.  From the point of view of Catholic social teaching, it should be highlighted 
that the focus is an all inclusive society. 
The most immediate benefit of germiline editing is personal:  my child, my family, my 
descendants.  Personal emotions carry a heavy weight in the decision-making process when a 
father or a mother believe they can free their future child and maybe grandchildren from a 
specific illness.  To intensify the emotions of this scenario, an illness they might blame 
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themselves for being the carriers.  From the legal point of view, in the United States, this general 
notion would fall under the ‘rights’ of the individuals:  the right to procreate and the right for 
children to be healthy.  In the situation where there is a high risk of illness, the possibility to have 
a healthy child that, with genetic corrections, can now survive the birth, the first few years of life 
and grow to be a healthy man or woman is very appealing to every parent.92  In many debates, 
parents advocate for their ‘right to have healthy children’, while others may present as a problem 
the fact that the child is not consenting to genome editing.  Even though parents are granted the 
right to choose what is best for their children and everyone believes that most parents would 
make the best decisions, the bottom line is that who is being impacted the most by this 
modification has no word and cannot express any consent whatsoever.93 
In the United States, the government is neither expected to financially support nor to 
promote reproductive technologies.94  In the Consolidated  Appropriation Act of 2016, the U.S. 
Congress stated, “None of the funds available by this Act may be used … in research in which a 
human embryo is intentionally created or modified to include a heritable genetic modification.”95   
That implies that this research is neither funded nor subsidized by the government, it is left to the 
private enterprises to invest their resources in it and therefore to provide the treatments when 
they will be available.  This reality in itself will result in a higher price tag due to the market 
dynamic of competition, offer and demand, etc.  If the government were to provide the financial 
support for the research, it would also be expected to disclose and share the information 
regarding the research.  Data would be made public.  Making the research public and sharing it 
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with other research institutions does not necessarily happen in the private sector.  Once the 
research is brought into the public arena, it allows for better oversight and a reduction of 
abuses.96 
As mentioned in the previous chapter, one of the concerns with any form of genetic 
editing is the off-target changes.  Since the research done with somatic illnesses is already ahead 
of those with inherited illnesses, the data provided can be very useful.  There is a threshold or 
limit of how much off-target editing should be tolerated before it actually impacts the body 
causing new problems.  In germline editing, because these new off-target mutations are also 
inherited and there is no knowledge available on how these mutations will be translated in future 
human generations, the level of tolerance should be lower than for somatic editing.97  Even with 
other living species, it does take multiple generations to determine the impact of the off-target 
changes.  The efficiency of scientific research comes from trial-and-error during the 
experimentation, and from collecting extensive data from all the trials.  Clearly, any valuable 
data that would be available in the human trials of germline editing would take years and even 
decades before it could be recollected and studied.  It would be necessary to observe the children 
and the grandchildren of those who underwent genetic editing.  Realistically, to study cases for a 
minimum of twenty years does neither sound appealing nor practical for the research team nor 
the patients, especially in this era when everything seems to move so fast.  Plus, there is the 
assumption that the person and their family would still want to be considered clinical subjects for 
scientific observation throughout those twenty or more years. 
On the one hand, some scientists themselves argue in favor of not editing the genome 
when this can cause inherited results.  Their approach is to let it be ‘natural’ and avoid to 
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intervene or impact the core of human life and design.  On the other hand, others argue that the 
genome has already been altered by what is present in the environment such as contamination 
and radiation.  These scientists believe that they would correct the mutations caused by a variety 
of these external factors, which in many cases were caused by humans themselves.  These two 
different and opposite positions on the issue becomes more complicated when the reality is that 
“(t)here is no single human genome shared by all of humanity.”98  Therefore, creating a master 
plan or model to which everyone should match or abide is unrealistic.  And if that were to 
happen, if a master model is set, then a few people would be determining for the rest of society 
what is normal and expected.  As it could be anticipated, that would affect those who are 
considered to deviate from the base line. 
As in the case of somatic editing, germline editing could have both positive and negative 
impacts for society.  In the case of germline editing the most obvious advantage is that the child 
and the family that once were considered physically behind the rest of society due to their health 
would now be at an acceptable health level.  If proven effective, this kind of treatment could 
reduce or even eradicate certain illnesses.  By eliminating those illnesses, those who would have 
been ill if the editing would have not taken place, as well as their family members, will have a 
better opportunity to overcome the physical, financial and psychological burdens connected to 
that illness.  This is all hypothetical, since there are other socio-economic factors that can be 
even more burdensome than a physical condition. 
The main negative impact on the community and on society would be trying to create 
perfect healthy children.  Our history has shown the ethical and social disasters that resulted from 
this approach.99  For example, if a procedure like CRISPR/Cas9 was accessible only to a limited 
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number of families and they were able to correct the mutations and therefore the diseases or 
conditions of their children, would those few families with access then become less tolerant to 
those in society who are struggling and will continue to struggle with the mutation and disease?  
There could be a regression in society’s acceptance of children and adults with these conditions.  
Unfortunately, this could foster the mentality of ‘better off if never born’ which is a quick 
troubling response to many scenarios of illness.  Those working for the rights and the dignity of 
people with disabilities tried so hard to eradicate this negative reaction and rejection.  There are 
concrete signs of how this attitude towards ‘imperfections’ continues to be present in society.  
Just notice the considerable decline in the possible numbers of babies born with Down 
syndrome.  Many parents choose non-existence over existence when they find out about their 
child’s genetic condition.100 
 
Human dignity 
Within Christian teaching there is a long tradition to define, recognize and uphold human 
dignity.  Throughout the centuries it has developed to the point of recognizing that every person 
– without distinction of race, gender, religion, education, religion or financial status – deserves 
respect and care by the simple fact of being a human being.  The Church tradition teaches that 
everyone has been created in the image and likeness of God.  The twentieth century brought that 
truth to new levels, and one of them concerns people with disabilities.  Now more than ever 
before, anyone struggling with any form of disability is encouraged and supported in order to 
integrate themselves as much as possible into society.  Among many things, special programs for 
education and training, as well as new equipments and technologies have been developed to 
assist people with disabilities to be part of everyday school, work and church life.  A sign of 
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these changes is that for centuries we built churches to be as high as possible to represent the 
nearness to heaven, now many of new churches are built without a single step to enter, and to the 
older buildings they are adding ramps and elevators.  At the same time, all the members of these 
communities are frequently reminded and challenged not to look down, not to reject those who 
are struggling physically or mentally.  If, on the one hand, genome editing is another tool that 
could help overcome a disability, on the other hand, some advocates for people with disabilities 
believe that this could be a step back.  They believe that once again they will and are already 
seen as imperfect and therefore they need to be ‘corrected’.101  Is there a real danger of reversing 
the progress made and returning to see people with disabilities as a mistake or a burden?  When 
we read and hear the arguments used in favor of genetic editing, the implication is that ‘people 
with these conditions need to be fixed’.  Without doubt, there is a desire to provide healing for 
those who are ill.  For centuries people have been searching for remedies and resources to 
facilitate healing.  The sad reality is when persons are defined by their illness.  How often society 
addressed a person as leper, “mongoloid” or “retarded”?  There are serious concerns that one of 
the results of reducing disabilities in society “will necessary decrease empathy, acceptance, or 
integration of those who have them.”102  This does not mean that nothing should be done to 
improve the health and the quality of life of a person with a disability.  It is more an issue of 
approach and mindset of the rest of society and the people involved in the research and 
treatment.  The language used with and in reference to the subject, and viewing the subject as a 
person and not an experiment, set the tone on how the illness and people are seen. 
The concept of human dignity needs to be cherished throughout the entire process: 
research and clinical trials with gametes, embryos, children or adults.  Frequently, our society, 
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including scientists, needs to be reminded that every person has dignity at every stage of their 
life.  Many societies improved in their acceptance of every living human being.  Where society 
still needs to be challenged is in allocating that dignity to every stage of humanity and not just to 
full living beings.  There is a need to express dignity even in caring for the dead.  Because they 
were humans, their bodies deserve due care and respect.  They should not just be dumped or 
abandoned until they decompose.  The rich variety of funeral rites shows that these dead bodies 
still carry the dignity that is owed to them.   
On the other side of the spectrum of life, it is also important to accept and promote the 
dignity of ‘future humans’, those who are not born yet but clearly will be persons with a rightly 
deserved dignity.103  In other words, we should advocate for the dignity of the fetus and the 
embryo.  Besides these three long standing stages of being human–past, present and future– the 
Rev. Dr. Jan C. Heller refers to the “problem of contingent future persons”.104  He highlights the 
lack of consent and freedom in the case of the newly created embryo.  A human life is now 
determined by the timing of the fertilization in the lab, the choosing of the desired egg, sperm 
and embryo, and genetically modifying them.  All these steps and decisions are being made by a 
mother and a father, and now also by a third party, which is not the child.  Even though there is 
love between the couple, the actual existence of this new life is not the result of a loving sexual 
act between the couple.  It depends on the work of scientist in a lab.  Procreation moved from a 
random manifestation of nature to the mechanical decisions and actions of a group of outsiders.  
Therefore, will these future human lives lose or be deprived of some of their human dignity 
because now depend on the work of some scientists in a lab?  Could this child be seen as the 
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property of a corporation?  An experience similar to this possible scenario that is already 
available for observation is the children being born by IVF.  These parents love their children.  
There is no doubt that these children are theirs.  The child is formed by the egg and sperm of 
mom and dad, maybe with pre-selection but without tampering the genetic makeup.  The 
difference in this new probable scenario would be that the genes are being modified.  Could this 
modification have an impact on the relationship between parents and child? 
 
Social justice 
An already existing ethical debate in dealing with and treating rare diseases is the amount 
of human and financial resources invested in this kind of research and clinical trials and whether 
these resources could be allocated to benefit and heal millions of people with diseases when 
there are already accessible treatments.  The limit of this statement is that, if for example the 
United States would stop or reduce the resources invested to study ‘rare’ illnesses, those 
resources would not necessarily be directed and used to attend global health issues.105  Without 
doubt, to find a cure for those rare genetic diseases is a sizable investment.  If the need to find a 
balance and a proportion between investing resources and the number of beneficiaries has a 
social justice overtone, without hesitation it is also a matter of social justice to find ways of 
healing someone even when they are among the unfortunate few suffering from health issues. 
By studying the history of humanity, there are several heartbreaking events that provide 
scenarios and obvious reasons to be concerned with the unknown long-term effects of germline 
editing.  It is possible that these modifications could create a sense of biological superiority and 
even supremacy.  They would impact everyday human interactions.106  There is even the concern 
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that what started as a healing mechanism could be distorted through time and be used in other 
less honorable, dignified and just ways.  As far as it can be predicted, if these modifications 
could actually take place, the result would not be a homogenous society, but most probably a 
subgroup within a society.  Once a subgroup is allowed to overcome a mutation in their 
germline, it leaves the ‘rest’ of society with the undesirable potential trait, fostering then a new 
level of prejudice.  “Genetic disease, once a universal common denominator, could instead 
become an artifact of class, geographic location, and culture.”107 
  The National Academies of Science, Engineering and Medicine acknowledge an 
openness to research with heritable genome editing as long as certain key criteria are fulfilled108 
and foster justice.  The argument is that there is no other alternative available and this method of 
genetic editing is the only way to prevent a specific illness.  The final product of the modification 
should match what is considered the normal standards in society and with very few or no off-
targets that can cause negative effects.  The data regarding the risks and benefits should be as 
accurate as possible.  There has to be a follow up of the patient but also of his or her descendants.  
In time, it will be necessary to assess the impact on society, and where this person fits within the 
society.  Finally, the most common approach to all research is to guarantee that there is no abuse 
or misuse of the technology.   
Ormond et al. stress that, “Future clinical application of human germline genome editing 
should not proceed unless, at a minimum, there is (a) a compelling medical rationale, (b) an 
evidence base that supports its clinical use, (c) an ethical justification, and (d) a transparent 
public process to solicit and incorporate stakeholder input.”109 
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 Going back in time, the Convention on Human Rights and Biomedicine of the Council of 
Europe in 1997 and the 1997 UNESCO’s Universal Declaration on the Human Genome and 
Human Rights requested that any tampering of the human genome should not be carried on by 
the descendants of the person.  This is a clear position that aims to avoid germline editing.110 
 
Solidarity 
 When the Catholic Church uses the term solidarity, she refers to that deep relationship 
between people, through which they share the joys but especially the struggles with a sincere 
empathy.  This care and compassion for the other move the heart to respond with the desire to 
foster, protect, and promote the well being of the other in every possible way.  That sense of 
solidarity serves as a driving force to care for people who are sharing the same socio-economic 
level, for those who are rich to look out for those who are poor and, among those who are sick 
and the healthy, to care for the ill.  Solidarity is the virtue that guarantees a just distribution of 
resources, not only because it is the right thing to do, but because ‘you are my brother, you are 
my sister and I care for your well being’. 
 In the case of germline editing, solidarity implies that all those involved–the scientists, 
those providing genetic material, the families of those who are sick or could be, the general 
public, the private businesses, the government and many others–are concerned about all the 
possible impacts of genetically editing a sperm or an egg, and the children that will be born from 
these modifications.  This sincere concern and protection cannot be limited to the present time.  
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Providing what is best must go beyond the children already born.  There should also be an 
awareness of those yet to come, the future generations.  A beautiful example of this solidarity 
beyond the present generation is all the hype about global changes in climate and contamination, 
and the commitment to guarantee a healthy planet for our grandchildren and their grandchildren.   
A simple way to be in solidarity with the communities of the developing world is to make 
sure that those who actually contributed to the research by being themselves part of the trials or 
providing resources, may reap from the benefits.  It is unfortunate when a country, a village or an 
individual that was actively involved in the experimentation stages of a medication or treatment, 
never get to benefit from what was achieved.  At the same time, all the participants involved in 
genetic editing need to recognize that if they are going to partake of the benefits they also have to 
share the burdens. 
 A sense of solidarity should be present in the debate about patents.  In the last few 
decades, there has been plenty of genetic research and discoveries.  For the most part, what 
scientists have done is ‘discover’ something that was already there, not necessarily creating 
something new.  The human genetic map is not a creation of an individual or a team; it is part of 
nature and it carries the genetic information regarding how the human body is made and 
functions.  With gene editing, what scientists did was to help uncover this information.  A patent 
is meant to protect an invention and not a discovery in nature; but there has been patent 
applications “filed for genes and segments of genes.”111  When dealing with how to use 
CRISPR/Cas 9 there is further debate: the editing mechanism can be found naturally in bacteria, 
but it is also true that it had to be modified in order to make the right DNA edits.112  Therefore, is 
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it technologically produced (invented) or natural?  The concern of turning it into a human 
creation is that it will involve patenting the CRISPR/Cas9.113  Patenting would imply having to 
pay for the license to use it, which would increase the cost of the procedure and enrich a few 
stakeholders.  Or patenting could be kept under the control of a few corporations.  The ideal 
would be for the scientists to see CRISPR/Cas9 as part of nature and take advantage of this 
opportunity to be in solidarity with other researchers by sharing their success stories, and in 
solidarity with those who are ill – maybe one day eradicating their illness.114 
 Last but not least, there has to be a level of solidarity towards the earth, the world in 
which we live.  Human beings have the responsibility to be good stewards of creation and protect 
it from being harmed.  When studying an array of mutations in the human body, many of them 
are caused by the environment.  Unfortunately, some of the environmental factors causing 
mutations, like chemicals and radiation, were created by humans.  These mutations are the 
consequences of humans exposing other humans to these risks.  With or without awareness, 
people are impacting the environment in negative ways and as a result of these actions they are at 
the same time causing negative effects on their own species and on the ecosystem.  (Maybe those 
creatures from the movie Rampage could become real after all!) 
 
Teaching of the Magisterium 
 The Catholic Magisterium has been slow in responding to gene editing, a technology that 
is developing very fast.  The main sources of teachings available are basically limited to Donum 
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Vitae (1987) and Dignitas personae: on Certain Bioethical Questions (2008).115  As it can be 
imagined, due to the later developments of these scientific discoveries, Scripture and Tradition 
lack direct insights in this area.  The early Church Fathers had no notion about genetics, and 
therefore could not incorporate them in their teachings.  But they experienced illness and cared 
for the sick. 
 One enlightening approach comes from St. Basil the Great.  In The Long Rules he writes 
about the art of medicine.  He explains: “In as much as our body is susceptible to various hurts, 
some attacking from without and some from within by reason of the food we eat, and since the 
body suffers affliction from both excess and efficiency, the medical art has been vouchsafed us 
by God, who directs our whole life, as a model for the cure of the soul, to guide us in the removal 
of what is superfluous and in the addition of what is lacking.”116  For Basil, it is important to help 
his readers understand that this “medical art was given to us to relieve the sick, in some degree at 
least.”117  God blessed humans with this art, but God is also providing the resources available in 
the world to be used for the healing.  “(T)he obtaining of that natural virtue which is in the roots 
and flowers, leaves, fruits, and juices, or in such metals or products of the sea as are found 
especially suitable for bodily health, is to be viewed in the same way as the procuring of food 
and drink.”118  But Basil recognizes that there has to be a limit to the amount of effort and to 
what is being sacrificed.  “Whatever requires an undue amount of thought or trouble or involves 
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a large expenditure of effort and causes our whole life to revolve, as it were, around solicitude 
for the flesh must be avoided by Christians.”119   
Maybe Basil’s most important contribution to his support of medicine concerns its 
purpose:  “Consequently, we must take great care to employ this medical art, if it should be 
necessary, not as making it wholly accountable for our state of health or illness, but as 
redounding to the glory of God and as a parallel to the care given the soul.”120  Basil concludes 
that whatever medical treatment is being done, it should be first and foremost for the spiritual 
well-being of the person, to bring people closer to God.  Treatment should be a path to God and a 
recognition that, when it works, the ultimate praise should be for the Lord, in order to avoid 
making medicine an idol.121 
Saint Basil also foreworns the reader about using the art of medicine in the wrong way, 
with a different and even harmful purpose for which God intended it to be used.122  At the same 
time, there is a long Christian tradition concerning suffering, which clearly has roots in the Old 
Testament, for example in the book of Job.  The spiritual challenge could also be accepting the 
disease with patience and as an opportunity to develop patience.123 
What did Saint Thomas Aquinas contribute to this topic, when he himself lacked 
knowledge about this genetic world?  In the Summa Theologiae (Ia, q.75 and q. 76), he wrote 
about the human soul, which gives substantial form to each person.  This means that it is what 
makes the human being a human, different from other animated creatures, but similar and 
connected to all other humans.  The soul allows people to understand who they are and what is 
everything else around them, something that, for Aquinas, a dog or any other animal cannot do.  
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Aquinas places the persons apart from plants and birds, but also acknowledges that they are 
neither angels nor God.  In simple words, the understanding and the will that humans possess 
place them in a different category.  They are not spiritual (non material) beings, but they are not 
solely material.  These previous concepts and teachings can be extrapolated and adapted to apply 
them to the present ethical questions raised by genetics.  For example, one of the practical 
conclusions that can be reached from Aquinas’ earlier arguments is that the human body should 
not be treated as all other minerals, vegetation or animals on the planet, since it is not just one 
more thing. 
 At the present time the main sources of Catholic teaching in regards to genetic editing 
can be found in Donum Vitae, Dignitas personae and the Catechism of the Catholic Church (no. 
2275, which quotes the previous two documents).124  When we read the arguments posed against 
genetic editing, and as a matter of fact against anything related to the human genes, the concerns 
at hand are mainly with IVF, the lack of sexual union to create life, and eugenics.  Since 
procedures of genetic editing are not yet fully developed, and therefore are not yet approved for 
human trials, one wonders what the theological reaction would be if gene editing was approved 
for trials.  Hypothetically, if genetic editing for an illness takes place within the sperm cells,  
causing modifications before cell differentiation, the egg is fertilized by the sperm when the 
couple has intercourse, and the development of the embryo is completely natural, without any 
outside intervention, would this scenario then be accepted by the Church’s Magisterium?125  
Clearly, IVF would not be needed and intercourse would occur without separation of the unity 
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and procreative dimensions, therefore they would be no-issues with the ‘new’ procedure; what 
remains is the question of eugenics. 
 Donum Vitae (no. I.6) states the following:  
Certain attempts to influence chromosomic or genetic inheritance are not 
therapeutic but are aimed at producing human beings selected according to sex 
or other predetermined qualities.  These manipulations are contrary to the 
personal dignity of the human being and his or her integrity and identity.  
Therefore in no way can they be justified on the grounds of possible beneficial 
consequences for future humanity. 
 
 This statement refers to selecting the gender of the child or “other predetermined 
qualities”.  The term ‘qualities’ addressed at the beginning of the sentence refers to non 
therapeutic conditions.  This could be parents looking to select the color of the eyes or another 
physical quality of their future child.  It seems that the main concern behind this statement is to 
avoid eugenics, which is a legitimate concern and will be addressed in the next chapter.  Could 
this statement indicate openness and acceptance to a certain type of editing that would be carried 
on genetically by the offspring, if what is being modified is an illness (therapeutic) in contrast to 
choosing characteristics (non therapeutic)? 
Twenty years after Donum Vitae, the Magisterium provided new insights with Dignitas 
personae.  In no. 26 the Declaration makes the following statement:   
Procedures used on somatic cells for strictly therapeutic purposes are in principle 
morally licit.  Such actions seek to restore the normal genetic configuration of the 
patient or to counter damage caused by genetic anomalies or those related to other 
pathologies. …  The moral evaluation of germ line cell therapy is different.  
Whatever genetic modifications are effected on the germ cells of a person will be 
transmitted to any potential offspring.  Because the risks connected to any genetic 
manipulation are considerable and as yet not fully controllable, in the present 
state of research, it is not morally permissible to act in a way that may cause 
possible harm to the resulting progeny.  In the hypothesis of gene therapy on the 
embryo, it needs to be added that this only takes place in the context of in vitro 
fertilization and thus runs up against all the ethical objections to such procedures. 
For these reasons, therefore, it must be stated that, in its current state, germ line 




On the one hand, this document supports somatic genetic editing, as long as it is 
therapeutic.  The procedures are restoring the human body to the ideal healthy level.  On the 
other hand, modifying the germline is illicit because of the “risks connected”, “yet not fully 
controllable”, and “in the context of in vitro fertilization”.  The first two arguments acknowledge 
that there are still unknown data and information.  As a general position towards human dignity, 
the body and the person should not be used randomly and carelessly for experimentation; 
definitely, ‘let us try this out and see what happens’ would not be condoned.  In spite of the 
teachings of the Church, however, researchers will continue to experiment until it is safe to have 
human trials.  Once these trials will show that the healing of the illness is carried out genetically 
without negative consequences to the offspring, scientists would address the conditions and 
concerns stated in Dignitas personae.  Would that be enough to sway the position from being 
morally illicit to licit? 
 
Scripture 
It is impossible to articulate a Christian theological discussion without relying on the 
Bible.  When looking for arguments within the Scriptures, the best texts that can be used to argue 
in favor and against germline editing come from the book of Genesis.  Those in favor of all or 
any aspect of genetic editing might read Genesis chapters 1-2.126  The supportive points are that 
everything that God created is good, and that God created human beings “in our image, after our 
likeness” (Gen 1:26).  “God created man in his image; in the divine image he created him; male 
and female he created them” (Gen 1:27).  That being the case, then humans are also co-creators 
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with God and are called to actively continue the evolution, the progression, the growth and the 
improvement of creation.  The Catechism of the Catholic Church states in no. 307: 
God thus enables men to be intelligent and free causes in order to complete the 
work of creation, to perfect its harmony for their own good and that of their 
neighbors.  Though often unconscious collaborators with God's will, they can also 
enter deliberately into the divine plan by their actions, their prayers and their 
sufferings.  They then fully become “God's fellow workers” and co-workers for 
his kingdom. 
 
This allows some people to conclude that this responsibility includes improving the human body.  
But if it is true that humans have this responsibility, they also have the duty to do so “in line with 
the divine intention.”127 
The second story of creation uses the images of clay and breath: “the Lord God formed 
the man out of the clay of the ground and blew into his nostrils the breath of life, and so man 
became a living being” (Gen 2:7).  This ‘clay’, this raw material, can be seen as that ‘common 
ground’ between all human beings and that which connects all of them with each other.  Some 
theologians see genetic material as sacred; hence, it should not be changed.128  Others would 
argue that the respect owed to the human body does not exclude introducing changes because the 
body, and therefore the person, has already experienced many changes throughout one’s life.129  
There are so many things that impact the body physically and therefore psychologically: 
education, environment, surgeries, etc.  All these external agents change the person and 
sometimes they have a profound impact on individuals and communities, but they do not reduce 
or eliminate human dignity and identity.  Due to arguments like these, some theologians can see 
the possibility of accepting genome editing, even in the case of germline cells.130 
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If, at any point, human trials will be permitted, there are at least two biblical perspectives 
or criteria that could be upheld.  Genesis 1:27 recalls the creation of humans in the image of God 
and therefore made free.  Therefore, the first expectation is that the children to be born should 
“be moral agents, that is, to be free.”131  Whatever is changed in the person should not affect that 
freedom.  Then, in Genesis 1:28, God commanded to “be fertile and multiply.”  Therefore, after 
genetic editing, the persons to be born “must retain their nature as men and women, and their 
ability to procreate as man and woman.”132 
To support their arguments some theologians who are against tampering the genes might 
rely on the same verses of Genesis chapters 1 and 2, with the difference that they could highlight 
that humans are still mere creatures and that by modifying the human body they are ‘playing 
God’.  This ‘playing God’ is a common phrase mostly used by secular and theological authors 
whenever there has been a direct intervention with the creation of life, e.g., IVF, cloning or 
genetic editing.  Another biblical support against tampering the germline may be found in 
Genesis 3:5.  Immediately after both accounts of Creation, the story presents the temptation: 
“you will be like gods who know what is good and what is bad” and the Fall that is caused by 
human pride.133  Clearly, there has been plenty of proof that when humans want to become God 
or be as powerful as a god, and the results were quite negative and destructive.  In order to 
conquer or balance pride, there needs to be an active practice and cultivation of humility. 
 
The virtue of humility  
In the City of God (XIV, 13) St. Augustine wrote about humility as a response to the 
pride of the Fall:   
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There is, therefore, something in humility which, strangely enough, exalts the 
heart, and something in pride which debases it.  This seems, indeed, to be 
contradictory, that loftiness should debase and lowliness exalt.  But pious 
humility enables us to submit to what is above us; and nothing is more exalted 
and above us than God; and therefore humility, by making us subject to God, 
exalts us.134  
  
Therefore, it is valuable is to foster the virtue of humility in the hearts of scientists and 
parents.  So that in developing genetic editing and in procreation itself, it is critical to put aside 
any unhealthy pride, which convinces the mind that we can make a better human being than the 
one made by God.  Humility acknowledges and accepts God’s ongoing intervention in creation.  
Humility allows us to receive and appreciate every child as a gift, a child with or without a defect 
or illness, a child in which God “blew into his nostrils the breath of life” (Gen 2:7). 
  
                                                          









Genetic editing to enhance some elements  
in the genetic makeup of the child 
 
Understanding enhancement and perfection 
Aiming for perfection is neither a new concept in the secular nor Christian traditions.  In 
his Sermon on the Mount Jesus himself taught his disciples to aspire for perfection:  “Be perfect 
as our heavenly Father is perfect” (Matt 5:48).  Since then to the present time, the challenge is to 
understand what is implied by the term ‘perfection’.  Based on biblical exegesis, theological 
developments and spirituality, perfection refers to completion, the person reaching the fullness of 
her capacity.135  What are those qualities, gifts and talents that persons should improve or perfect 
within themselves?  Since God created each person with particular and distinct characteristics, 
each person should not only work on improving these, but must also do it so that one’s whole life 
reaches its fullness.  And this perfection can only be reached with God’s help.  As Christians, we 
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believe that the absolute fullness of perfection will only be achieved once the person reunites 
with God in heaven, since “heaven is the ultimate end and fulfillment of the deepest human 
longings, the state of supreme, definitive happiness.”136 
In the Summa Theologiae (I, q.4) Thomas Aquinas explains how all perfection in the 
world is achieved through God, since God is the source and the cause of perfection.  God’s 
perfection implies that there is no need or space for improvement.  It is already reached.  Since 
human existence is dependent on God, human beings share in the perfection of the one who 
created them.  “All created things, so far as they are beings, are like God as the first and 
universal principle of all being”137  (I, q.4 art. 3).  Therefore, existence and perfection are gifts 
from God, which the human being receives and enjoys, often without acknowledging the source. 
A difficulty with this understanding of perfection is that it has a strong Christian 
foundation, and therefore, not everyone will agree with it.  Civil society relies on other versions 
of perfection, sometimes focusing on external appearance or financial gain.138  Obviously, these 
perfections are based on standards created or defined by the society of the time; therefore, these 
standards will change throughout the years.  At the same time, caution must be taken that 
perfection is not distorted into a false sense of personal dislike.139  Instead of improving the self, 
people might desire to change their being to become some ‘other perfect’ being.  Many times 
that desired perfection is someone else’s lifestyle, appearance, family life or possessions.  As 
described earlier, perfection is bringing the potential of who we are to its fullness.  And since 
each person is made different, the ‘final perfect product’ must also be different.  The challenge is 
to believe and accept that if perfection brings us closer to God, who is the source of all attributes, 
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then God is the one setting the goal.  When God’s call, vision, and gifts are not recognized and 
considered as part of the person’s ultimate goal, one of the dangers is to turn the personal 
experience in what is normative.140  Unfortunately, some people have underestimated their own 
capacity and level of perfection, which may cause on certain occasions to be off-track or short 
from being as perfect as they could be in this life. 
Today the term perfection is also translated or equated to the concept of enhancement.  
The Merriam-Webster Dictionary defines ‘enhance’ as “to increase or improve in value, quality, 
desirability, or attractiveness.”141  It is interesting to note that to enhance is commonly applied to 
objects: people work hard to enhance cars, houses, and technology.  Within certain social circles, 
now the term is frequently used, accepted, and promoted for human beings.  This approach may 
be observed when, through utilitarian and materialistic lenses, the human body and the person 
may be seen as one more product or thing to be improved, enhanced and, therefore, perfected.  
Since every person is called by God to be perfect, this desire for perfection moves them 
to go beyond the self, towards other people and things around them.  Within the richness of 
cultures and countries, all human beings share similar relational dynamics towards themselves 
and the rest of humanity.  Humans naturally care and protect their own selves.  The need to be 
nourished, healthy, sheltered and safe from any harm are some examples of basic common 
motivations across the borders of space and time.  Moreover, human beings do not live in 
isolation.  They are born and raised within a family and a community which fostered that sense 
of responsibility for the well-being of their neighbor.  Then, when humans are concerned about 
having perfect conditions for themselves and their community, they become more aware and 
                                                          




better stewards of the whole creation.  It is this natural human reality that calls for solidarity 
towards oneself, the neighbor, and the entire world.142 
In the previous chapters, genetic editing with CRISPR/Cas9 was considered as a 
possibility to heal or to prevent an illness.  Without any doubt that would be a dream turned into 
reality for many parents and grandparents who also suffer due to the struggles of their little ones.  
This dream would be to free people from illness, pain, premature death, and some would even 
say, to provide for them a ‘normal’ life.  In the present time, depending on the illness or 
condition, it remains only a dream or hope. 
 Enhancement, however, is quite different.  The dream or proposal is not to help a person 
or family to overcome an illness, but to find ways to improve certain qualities of the child.  The 
intentions are not to heal, but as it is commonly said, ‘to enhance.’ 
At the same time, we need to remember that the technology for enhancement with genetic 
editing would be also using CRISPR.  And it could be applied on both: somatic cells or germline. 
 
The role of eugenics 
Throughout the history of humanity one of the common struggles, which every culture 
had to face and to address, was how to deal with the sick and disabled members of the society, 
those members of the community that could be contagious, could not be self-sufficient and 
independent, or could be considered a ‘burden’ to their family and society.  We can try to 
imagine several centuries ago how difficult it must have been to diagnose and treat certain 
illnesses, especially in the case of communities or families with limited resources, knowledge, 
and medical technology.  During the nineteenth and twentieth centuries, humanity found new 
                                                          




ways of addressing illnesses and treatments.  Since then, scientists have been discovering and 
gathering more information about hereditary illnesses and conditions, about genes and 
chromosomes even at the point of providing new solutions to diagnose and treat some of them. 
In an ethically problematic way, the ‘science of eugenics’ was formally introduced to 
improve the qualities of a race or a community by encouraging the human mating of certain 
individuals but prohibiting it for others.  Therefore, in the Merriam-Webster Dictionary, the 
word eugenics is defined as: “a science that deals with the improvement (as by control of human 
mating) of hereditary qualities of a race or breed.”143  This scientific and social approach 
impacted society in such a way that those who had the genetic traits that were considered socially 
undesirable were in some cases sterilized.144  Quite often the people sterilized were living in 
mental institutions or were immigrants.  Some ethnic groups, which were considered as inferior 
by dominant white Caucasians, experienced rejection from those with political and/or financial 
power, even to the level of becoming victims of genocide.  As deplorable as these actions seem 
to us now, what happened in Nazi Germany, is still lingering or creeping into different societies 
with similar premises (a sense of superiority) or desires (purify or improve the race).  This 
unacceptable racist mentality can be observed even in some of the television news broadcasting, 
when those interviewed make comments or are holding signs with degrading contents about 
certain groups of peoples.   
As a result of such a horrendous use of science, many countries and the United Nations  
created laws, policies and inspection teams, which try to respond as soon as possible when the 
leaders of a nation or certain groups give signs of targeting another ethnic or religious group.  
Unfortunately, these defenders have neither been quick responders at all times, nor effective in 
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stopping those who believe in and practice eugenics and racial discrimination.  The sad reality is 
that sometimes these experimental practices can be taking place out of the sight of inspectors and 
enforcers of human rights.  Therefore, targeted individuals and groups can still be the source of 
racial and eugenic experimentation aiming at extinction or at least control of their growth within 
the community. 
The eugenic mindset tries to give the impression of pursuing almost an altruistic cause.  
For example, eugenics claims that it wants to improve the human race by increasing the levels of 
intelligence of chosen individuals.  Moreover, eugenics claims that it can influence and even 
accelerate human evolution, which could take thousands of millions of years without any 
intervention.145  Too slow for some people!  Basically, the eugenic goal is to accelerate 
biological evolution by enhancing the genetic characteristics of a child or of a whole group 
within the society.  What eugenics seems to forget is that nature has its own course and time 
frame.  At this point in time, it would be impossible to predict what would be the natural result of 
human development if allowed to run its natural process for centuries.  It is impossible to predict 
and replace natural selection.146  The desired outcome of genetic editing might sound like and 
could actually be considered by some a noble one; but what needs to be observed and evaluated 
is the mentality of those who promote genetic enhancement now by comparing it with those who 
have tried to achieve these improvements in the past. 
With the DNA discoveries in the 1950s and 1960s, a new level of eugenics began.147  The 
goal was not to match the ‘right people’ together in order for them to give birth to healthier 
children or to discourage or make sure that the ‘undesirables’ would not procreate.  New 
scientific methods were developed attempting to avoid or reduce the number of people born with 
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unwanted conditions.  In the practice of eugenics in the 1920s and 1930s, to control healthy 
genetic combinations, no external or third party intervention in the actual process of procreation 
was possible.  People were born after the traditional intercourse between a man and a woman.  In 
the latter part of the twentieth century, with reproductive technologies, a new era began and it 
became possible to choose the egg or sperm, or embryo.   
 
Imperfections and sufferings 
Social pressure is a relevant factor in ethical decision-making.  Family members, friends 
and public media are often pushing couples to have not just a healthy child but a ‘perfect’ child.  
When science is able to reduce or eliminate the possible genetic illnesses of a child, it “solves 
two problems at once:  it relieves suffering, and it is less costly in terms of personal commitment 
and economic outlay.”148  The high cost of living in developed countries, including healthcare, 
might discourage families and communities to accept open-handed a person affected by a long 
term illness or condition.  In some developing countries with higher levels of poverty, a variety 
of programs and incentives have been promoted to discourage having children in general.   
Suffering deserves its own attention.  In Western civilization, increasingly there seems to 
be a greater difficulty handling the experience of suffering.  There is an increased aversion to 
face the physical pain in one’s own body and, at the same time, the personal sacrifice necessary 
in caring for someone else who is ill or suffers from a disability.  All forms of suffering seem 
futile, and therefore, there is an inability to deal with my own or another’s physical struggles in a 
constructive way.  This approach is completely opposite to an older but still present philosophy 
of life that would say: “offer it up” or “I am offering this suffering for…”  Among the signs of 
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this lack of tolerance for suffering is the number of people self-medicating and consuming all 
sorts of drugs and other substances.   
In my ministry, I personally witnessed an increased number of young people cutting 
themselves, attempting or committing suicide as their way to deal with their struggles and long 
term issues that make them suffer.  Many of these young men and women are not learning how 
to face psychologically and spiritually their own sufferings in a healthy way.  As they become 
adults, we can only wonder will they be able to cope with the long-term illness or handicap of 
their child.   
The Catechism of the Catholic Church states in a very simple way a very powerful 
reality, “The way of perfection passes by way of the Cross.”149  In the Gospel of Matthew 16:24, 
Jesus told his listeners that in order to follow him, they had to pick up their cross.  A phrase from 
one of Archbishop Fulton Sheen’s Easter homilies, that has been quoted often, reminds us that 
“unless there is a Good Friday in her (the Church) life, there will never be an Easter Sunday.”150  
It is critical to understand that what Jesus, the Catechism, and Archbishop Sheen are saying does 
not mean that it is acceptable or even good to be victims of injustice and abuse.  These and all 
other forms of violence against the person cannot be seen as the cross that Christ wants them to 
carry in order to reach the glory of Easter.  What these voices are trying to teach us is that in the 
Christian journey towards perfection there will be some suffering.  And as mentioned before, 
suffering can be caused by the personal physical struggles or by sharing the struggles of someone 
we love.  Even athletes and trainers acknowledge that there is ‘no pain, no gain’ in order to 
become better athletes.  Doctors and patients recognize that the physical pain during the recovery 
from a surgery and the physical therapy are part of improving one’s health.  By the same token, 
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if the personal target in life is to achieve true perfection, then some level of suffering is 
unavoidable and learning how to face one’s struggles is necessary.  Similar to the trainee or the 
patient, some days this is not exactly what people want to hear! 
If experiencing some suffering is part of the spiritual road to perfection, is there a place 
for fear in that journey?  Clearly, people fear the possibility of becoming ill; they fear pain, 
suffering, seeing their loved one suffer, and ultimately, many fear facing their own death.  It is 
impossible not to have some level of fear.  Being afraid is not necessarily a sign of lack of faith 
or trust in God.  Jesus himself experienced some fear that night at the Mount of Olives as the 
crushing passion was about to begin.  “He took with him Peter, James and John, and began to be 
troubled and distressed.  Then he said to them, ‘My soul is sorrowful even to death.’”151  Jesus 
looked for comfort and strength in prayer, and turned to God and to his loved ones, his friends.  
The challenge for him and for all of us is to avoid or at least control despair, anxiety, anger, 
doubt, resentment or all of them combined.  The challenging task in those moments of fear is to 
trust and hope that God will provide the comfort and grace needed to face any form of suffering, 
even the scariest of all: death.  Saint Paul wrote to the Corinthians “Death is swallowed up in 
victory.”152  And he continued, “But thanks be to God who gives us the victory through our Lord 
Jesus Christ.  Therefore, my beloved brothers, be firm, steadfast, always fully devoted to the 
work of the Lord, knowing that in the Lord your labor is not in vain.”153  Within Christian 
spirituality, some type of fear might have its proper place.154  Some theologians call it religious 
fear,155 by stressing how the conscience awakens and desires to be faithful to God out of love 
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and reverence.  Ultimately, according to the Gospels, the only thing we should be completely 
afraid of is spiritual death,156 that which kills the soul157 and pushes us away from the love that 
God has for us.    
 
Beyond health issues 
Individuals, families, scientists, and communities have to deal with health or challenging 
health conditions.  What happens when we decide what we can or cannot bear? 
Every parent desires that their children be born healthy and that they grow up with the 
least challenges and disadvantages as possible.  Most parents, if they had the opportunity, would 
remove all the obstacles that could harm or affect their children.  These are noble intentions and 
there is nothing wrong with this good will towards one’s own child or, as a matter of fact, 
towards any child.  Parents search for the best schools, programs, and activities to enhance the 
opportunities of development of their children.  Even in developing countries, parents will 
undergo huge sacrifices so that their children may receive education or even something more 
essential, like healthy food.  Therefore, it is not surprising that given the opportunity to improve 
the odds of their children, parents might consider certain genetic changes.  As mentioned earlier, 
there are changes related to health, but there are other modifications considered to be 
enhancements or choices.  All through the pregnancy, after birth and until their independence, 
parents are constantly making choices on behalf of their children.  Some will argue that if parents 
are careful in choosing which schools their children will attend, and provide all other forms of 
assistance such as tutors and computers to improve the chances of obtaining a better education, 
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then why not try to enhance the genes that impact their intelligence?158  The argument made by 
parents and scientists can be summarized as:  If the final result is good for the child and it is done 
with good intentions, then it should be acceptable to proceed with the enhancements. 
It is true that so many things are already being done to improve the physical, intellectual, 
and emotional well-being of the child.  However, prudence is needed to determine how far 
parents and scientists should be allowed to go in order to fulfill the desire of having a ‘perfect’ 
baby, a ‘perfect’ child.  Quite often there are too many variables impacting the development and 
growth of a child.  It is naïve to believe that everything will be under control by relying simply 
on genetic modification.  The best proof of this uncertainty is the everyday experience of rearing 
children.  How often parents cannot explain why, after following the same education and 
discipline, their children may turn out to be so different from each other.  It would be naïve for 
parents to believe that their children will grow up and be ‘perfect’ because they modified their 
genetic sequence.  It is impossible to guarantee that some of the enhancements made to the genes 
of an embryo will manifest themselves in the child and adult as they develop.  
 
What is normal, average, and natural 
Another important aspect to address is defining the parameters of what is normal, 
average, and natural, when the use of such terms is referring to a range of qualities that are found 
in the members of a society and therefore are considered acceptable.  For example, there is not 
an exact height for a man or woman, but a range where the majority of people can be found.  
Therefore, when someone is outside the range by being too short or too tall, some within the 
general population consider this person to be somehow defective.  The line between being 
normal or not is more clearly drawn when the differences are the result of diseases caused by a 
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virus, bacteria, or exposure to unhealthy materials in the environment (i.e., pollutants, asbestos, 
lead, and radiations).   
The other term we should consider is natural, which defines what followed the course of 
nature without intervention.  As examples, in the twenty-first century, in the developed countries, 
there is a growing number of consumers who are longing for ‘natural’ foods and expecting 
mothers want to have their babies at home with a midwife and without any medication.  This 
desire to avoid genetically modified foods or avoiding food that has been exposed to chemicals, 
or give birth naturally as a way to return to what is simple, healthy, and unspoiled, clashes with a 
whole different approach within society.  While some want everything to be as natural as 
possible, others have their bodies bombarded with more medications and chemical substances 
than ever before; natural phenomena like procreation are replaced by artificial procreation in the 
case of infertile and sterile couples; and there is the desire to modify and manipulate the human 
genetic makeup.  It is interesting to observe a new social trend: everything that is considered 
organic, and therefore natural, is considered to be better and healthier.  Ironically, at the same 
time, in other circles, the desire for what is ‘completely natural’ is perceived as less important 
and it is compromised particularly in what concerns the creation of human life and the 
modification of the human body. 
People are already experiencing different levels of enhancements:  short-term (energy 
drink), long-term (corrective surgery), putting their own effort (practicing and training for 
sports), being a passive recipient (wearing teeth braces).159  These diverse types of enhancements 
are important.  Within society, and this includes family members, people show great pride when 
an individual works hard and extensively to improve his or her physical condition.  The opposite 
is also true; there is shame and even negative consequences (so far) when athletes artificially 
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improve their muscle mass.  This tug of war is exemplified when considering the reactions of the 
media, the fans, and other players when a baseball player in the Major League Baseball was 
suspended for using performance enhancement drugs.160   
The term enhancement is used for a spectrum of scenarios in which a person is improving 
the present condition.  For an individual born with a condition that most people in society 
consider it to be negative, to be enhanced could mean overcoming or being healed from the 
present status and having a ‘normal’ life.  For a person considered to be already healthy, 
enhancement might be improving a quality that places ahead or above the average population.  In 
the case of genetic editing or any other treatment, this contrast between restoring health and 
improving beyond the average should be taken under account.  There is a critical difference 
between helping a person reach the level of ‘normal’ and ‘average’, and improving one’s 
capacity above the average or norm.161 
Another issue to be considered is who determines what is a disease, what is not ‘normal’ 
and needs to be corrected.  As noted in history, there was a time when being a homosexual or a 
criminal was considered an illness and scientists tried to correct them therapeutically, obviously 
without success.162  It is impossible to remove completely the personal and cultural bias of those 
making decisions of what should be considered an unacceptable condition, and therefore, that 
what should be treated in order to overcome it. 
In discussing the contrast between healing and enhancement procedures, there is 
nowadays a third area to be considered:  preventive medicine.  Clearly, the procedures or 
                                                          
160 “Saturday afternoon (September 7, 2019) Major League Baseball announced Minnesota Twins right-hander 
Michael Pineda has been suspended 60 games after testing positive for Hydrochlorothiazide, a diuretic and common 
masking agent for performance-enhancing drugs.  The suspension begins immediately.” See 
https://www.cbssports.com/mlb/news/twins-michael-pineda-suspended-60-games-after-testing-positive-for-
performance-enhancing-drug-masking-agent/. 
161 See National Academy, Human Genome Editing, 145. 
162 See ibid., 148. 
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treatments used in preventive medicine are neither healing an illness nor setting the person above 
the rest, but they aim to protect their health and well-being.  The most classic and common 
preventive medicine already practiced is immunization, vaccinating the person from an early 
age.163  As with the vaccines, many preventive medicines have proven to be beneficial for the 
quality of life of individuals and communities.  The concern is if preventive medicine is only 
available in certain countries and accessible to specific groups of people, then it can enhance the 
life of a segment of the population over another.   
As described earlier, there are many ways of understanding and evaluating an 
enhancement.  It could be considered as a negative practice or option when it “confers a social 
advantage beyond that which an individual possesses by fate or through personal effort, and that 
does not benefit the rest of society…”164  In other words, serious questions and concerns need to 
be raised if the person that will be enhanced is not affected by any disease and, at the same time, 
the purpose is to place that person above others.  This would create an elite including only a few 
chosen ones, neither because of natural development nor as a result of individual’s personal 
labor.  
 
Other concerns with enhancements 
A first important concern is how children are treated.  If a child has been enhanced, 
automatically the parents and other people in society will consider the other children as lacking 
those ‘great qualities’ or ‘perfection’.  Some may argue that this comparison may not happen at 
all.  The only way to have a glimpse of the future is to observe present practices.  Parents 
compare, and in some cases brag, about the levels of competence of their children, let it be 
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academically or athletically.  Of course, it is hard not to brag about the excellent grades of a son 
in high school and the amazing performance of a daughter in a basketball game.  The danger is 
when the average child in the classroom or on the court is looked down as inferior, as if they had 
a disability because they are not able to perform as well.  It is not just in movies that the over-
achievers have undermining looks and degrading comments towards those children who 
performed differently.   
In a hypothetical future with enhanced children, there could also be negative reactions 
towards parents who cannot afford to enhance their child or choose not to do so.165  Such a 
choice might suggest to some that those parents do not care about the well being of their 
children.  An elite mindset and negative reactions can already be seen towards families who 
cannot afford the expensive sports camps or private schools with accelerated academic programs.  
Working in an expensive private high school, I witnessed tensions between those who can afford 
the full tuition and those who depend on scholarships.  Nothing new; these are the same old 
frictions between those who have and those who have not.  If genetic enhancement will be used 
on people, it seems that all members of society will have to consciously take upon themselves 
the task of avoiding any pejorative attitude, discrimination, and pity towards the children who 
will not be enhanced.  
 
Chance or choice 
If genetic editing is applied to humans for enhancements, there would be a move from 
chance to choice.  What would be the impact on that particular genetically enhanced child, but 
also on the dignity of children in general, if children could be enhanced?  Humans have a wide 
range of qualities and abilities.  Part of the richness of humanity is the mingling and interaction 
                                                          
165 See Cahill, Theological Bioethics, 214. 
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between all these possibilities: different heights, color of skin, muscle strength and abilities for 
math, music and sports.  The possibility of being made or tampered with, not naturally conceived 
and received, can lead to objectification.  The child can then become the product of the parents’ 
making and design, and not necessarily the unconditional and generous embodiment of their 
love.166  Even if an enhanced child is objectified, he or she will not lose human dignity.  
Moreover, if scientists were able to perform multiple enhancements to the embryo, it will be 
interesting to see how the family, and the people working in the lab, see this child. 
Some people may argue that the ability to take control of what is best for one’s children, 
by making these choices and having the freedom to do so, actually means honoring our 
humanness.  Parents and scientists are using their gifts, talents, and possibilities.  Such a 
statement is true for those who can make decisions.  They are responding to the call to be 
creative, to use their knowledge and resources to improve their descendants.  However, in 
arguing in favor of the right and ‘blessed’ opportunity to choose to enhance, it should be noticed 
that those being impacted the most (the children) have no say about those changes; they have no 
freedom to choose.167 
 
Governance 
As mentioned in Chapter One, when treating somatic diseases the United States Food and 
Drug Administration would regulate genetic editing, as well as the Recombinant DNA Advisory 
Committee, institutional biosafety committees, institutional review boards, and the US 
legislature.168  A concern with all medications and treatments is that physicians have a certain 
freedom of judgment that allows them to use medications and/or treatments in other 
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circumstances beyond the original conditions for which they were intended.  Therefore, there is a 
possibility that physicians could use this freedom or flexibility to recommend genetic editing for 
enhancements instead of treating an illness. 
From a social justice perspective, it is worrisome the amount of financial resources 
invested in pursuing enhancement.  The resources that could be used to enhance the body of 
someone who is actually healthy, could be used to benefit so many in the world who lack the 
basic medical treatments.  This way of reflecting about health may be a pressing concern for 
some governmental agencies, but less when research and applications are privately funded. 
 
The virtue of love 
I conclude this chapter on enhancement by referring to the virtue of love.  The apostle 
Paul wrote to the Corinthians that love should not be jealous or rude, but patient, kind and should 
bear all things (see 1 Cor 13).  This God-given virtue empowers us to love one another, even our 
enemies, to love those who hurt us, those who are imperfect, those who God has entrusted to our 
care and protection.  In some ways, many genetic and scientific advances can threaten love.  
How is that possible?  Every mother and father is called to love their children, to accept them for 
who they are, with their strengths and weaknesses, character flaws, unique traits, infirmities, and 
physical disabilities.  Love cannot and should not be conditioned to what the parents expect their 
children to become as they grow, or what the parents designed them to be.  Love will assist 
parents to care for their children so that they can overcome or deal with their limitations.  Love 
will also grant the parents what they need to face the suffering connected with their children’s 
79 
 
struggles.  As Paul says, “For we know partially and we prophesy partially, but when the perfect 
comes, the partial will pass away.”169  If it is perfection that the person desires, love is essential. 
 
  
                                                          






   Chapter 
 
 
Some spiritual tools for discerning gene editing 
 
 In our faith tradition, Christians are encouraged to discern when facing daily life 
experiences, but especially in those critical moments when they need to make life-changing 
decisions.  Whether society should engage in genetic editing, if it is the best healing option for 
my family or myself, if it respects human dignity and rights: these are some of the questions that 
require an ongoing discernment.  Without any doubt, the actions and words of Jesus can and 
should enlighten this process. 
 
Jesus, the exemplar 
Scripture shows how often Jesus went to pray, especially as he was about to face difficult 
circumstances.  As mentioned in Chapter Three, the night of his betrayal he went to pray in the 
garden at Gethsemane.  He even asked his apostles to pray with him, but they were unable to 
keep up.  Did he get discouraged?  It seems like he was frustrated with them, but that was no 
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excuse to stop praying.  He kept going back over and over to pray (Matt 26:36-44).  Prayer 
offered him the strength and peace he needed.  In every discernment, it is necessary to increase 
our personal prayer and, at the same time, to invite others to join us by praying for us and with 
us. 
All through his life and ministry, Jesus showed a profound compassion for others.  This 
compassion was manifested to the very end of his life: when he washed the feet of his disciples 
(John 13:1-14), gave his body and blood at the Last Supper for spiritual nourishment (Matt 
26:26-28), healed a wounded persecutor (Luke 22:50-51) and, from the pulpit of the cross, he 
forgave the crowd and the repentant thief: “Amen, I say to you, today you will be with me in 
Paradise” (Luke 23:43).  In the midst of his pain, Jesus made sure that his widowed mother 
would be protected and cared for by his friend and faithful disciple, John.170  During his passion 
and death, Jesus was not only compassionate, but he also welcomed compassion from others.  He 
allowed Simon the Cyrenian to assist him with carrying the cross (Matt 27:32).  Even after his 
death, he relied on the kindness of others to provide the proper burial, among them Joseph of 
Arimathea who “taking the body, wrapped it in clean linen and laid it in his new tomb that he 
had hewn in the rock” (Matt 27:59-60a).  How beautiful and powerful it is to show compassion 
to those who need it, and to be humble enough to receive it from others when we are those in 
need.   
As a teacher, Jesus provided a prime example of solidarity and fidelity with those who 
were suffering.  The Gospel stories about the death of someone else and how Jesus reacted may 
cause some confusion.  When Jairus (Mark 5:35-43), the widow of Nain (Luke 7:11-16), and 
                                                          
170 John 19:25-27: “Standing by the cross of Jesus were his mother and his mother’s sister, Mary the wife of Clopas, 
and Mary of Magdala.  When Jesus saw his mother and the disciple there whom he loved, he said to his mother, 
‘Woman, behold, your son.’  Then he said to the disciple, ‘Behold, your mother.’  And from that hour the disciple 
took her into his home.” 
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Martha and Mary (John 11:1-44), lost his daughter, her son and their brother respectively, Jesus 
brought those dead back to life.  It may give to some readers the impression that there is 
something wrong with dying.  To add to the confusion, why did Jesus cry before the tomb of 
Lazarus?  What can we learn from Jesus in regards to our response to suffering and death of 
others?  The reactions of Jesus restoring life and crying were not a result of doubting the 
goodness of the afterlife, seeing death as an evil that must be avoided at all cost, or incapacity to 
deal with the death of a loved one.  In these and other cases, Jesus is showing solidarity and 
fidelity171 with those who are mourning.  If fidelity is that virtue by which relationships are 
fostered by responding to the needs of others, then these acts of healing and bringing back to life 
can be seen as more of a compassionate response to the mourners who are living, than solely to 
the people who were dead.  This is a reminder that the family and caregivers of those who are ill 
or with a disability also need care and support.  As they mourn due to the sufferings of their 
loved ones, they need spiritual, emotional, material, relational, and physical support.  
Without any doubt, the crowds were highly impressed with Jesus’ healing actions, all of 
which showed compassion, solidarity, and fidelity.  Besides being sick, most of them were also 
outcast, rejected by the society and even their own family.  When he healed the ten men with 
leprosy (Luke 17:11-19), the woman suffering with hemorrhages for twelve years (Mark 5:25-
34), and many other sick people, he restored their health but also their rightful place in society.  
As the Word made flesh, Jesus reveals to us God’s desire to heal us.  Therefore, there is a Christ-
like attitude and a God-like task in trying to heal others from their illnesses, to rescue them from 
pain and isolation, and to restore them to a fullness of life.   
Throughout the Gospels, Jesus shows how healings are signs that the reign of God is at 
hand.  What does that imply?  First and foremost, anyone who is “broken off from friends, 
                                                          
171 See James Keenan, “Proposing Cardinal Virtues,” Theological Studies 56, no. 4 (1995), 725. 
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family and God”172 due to an illness should experience, through the act of healing, reconciliation 
with all of the above.  This reconciling healing is not limited to the individual who is cured but 
also impacts the community.  The family and friends also experience this healing and 
reconciliation with each other and with the rest of society.  As we have seen many times, the 
isolation and marginalization is not limited to the person who is sick.  Quite often the family 
members who function as caregivers are isolated by their own choice when there is a sense of 
shame and embarrassment due to their ill relative, or because other members of the community 
have ‘pushed them away.’  (When I was growing up, I saw this happen too often when a family 
had a child with Down syndrome.)  The hope is that by restoring the physical health of the 
individual, that person and their entire family are restored within the community. 
Second, the healing must go beyond the fact of no longer being sick.  There has to be a 
‘follow up’ of service, which implies caring for others as or better than how they were cared for, 
and as a way of showing gratitude to God.173 
Third, if healing and reconciliation are part of the reign of God, then everyone should be 
part of the action.  As the first disciples, we are all called to the best of our ability to restore as 
many people as possible.  And if by any chance we are unable to be effective in the healing 
process itself, then to be at least supportive of those who can.  Following the example of Jesus, 
then we must remove “people from positions of dependence and marginalization… (freeing) 
them not only from bodily misery but also from the social stigmas that ostracized them.”174   
At different times in the Gospel, Jesus foreworns about false prophets; therefore, it is 
necessary to recognize the ‘false healings and healers.’  These are the ones who do not work 
                                                          
172 Terrence W. Tilley, The Disciples’ Jesus: Christology as Reconciling Practice (Maryknoll, NY: Orbis Books, 
2008), 142. 
173 See ibid., 143. 
174 Ibid., 145-146. 
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towards the realization of God’s reign.175  This indifference, or even sometimes opposition, can 
be determined when there is an absence of joy, because there was no reconciliation and 
restoration with society.176  If the focus is just to cure a disease, and not caring for the person, 
then the task is half done.177  We are in a time in the USA when the insurance companies rule 
and dictate the care that is offered to those insured, and many times with a strong for-profit 
approach.  Hence, many with actual health issues are left unattended, while often efforts and 
resources are placed on cosmetic issues for some.178  With the possibility of genetic editing, what 
will happen if enhancements are more profitable than healing somatic illnesses? 
Jesus believed that God was there, in place and time, when he was about to endure his 
passion and death; and trusted that God would carry him through it.  This trust gave him the 
freedom to surrender any control and to allow others to take over his physical life out of love.  
This became obvious when he did not run away before or during the arrest.179  Trusting God was 
accompanied by hope in the afterlife.  He knew that after his agony and death God would receive 
him and entrust to him the gift of the resurrection.180  Maybe this is one of the toughest 
challenges: to let go of our control; to surrender and acknowledge that sometimes there is 
nothing we can do to change what is happening to us or to others. 
 
The challenge of Jesus 
One of the difficulties that people have nowadays, when they compare their sufferings 
with Jesus’, is that what they are going through seems meaningless in contrast to the redemptive 
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value of the death of Jesus.181  If “the suffering of Jesus is understood as his bearing the sins of 
humanity,”182 then it is true that we are definitely unable to compare with his purpose and 
effects.  But it is also true that we are called to share in the sufferings of Christ.183  His suffering 
can be considered “as an ingredient in the process by which followers become conformed to his 
image.”184   
Another challenge is Job’s experience in the Old Testament, in which he lacks 
understanding as to why he has to suffer.  Job is not questioning God’s existence.  Like many 
other people, he questions why does she or he or I have to suffer, especially when we are under 
the impression of being good and faithful people.  What is presupposed is that pain and suffering 
are reserved for those who have done wrong in life.  With the book of Job, the Judeo-Christian 
tradition begins to discuss “that suffering is natural to humans simply because they are 
humans,”185 not necessarily as a punishment for wrongdoing.  The new Job–Jesus–became the 
ultimate example to discredit this former (although sometimes still present) mentality.  Even 
Pontius Pilate publicly recognized Jesus’ innocence before condemning him to death (John 
19:4).  At the same time, Jesus gives witness that “the experience of pain is not optional,”186 not 
for him and not for any of us.  And he also teaches the importance of being humble when the 
time comes to face suffering.  First, we all need humility to recognize that our sufferings and 
death do not and cannot fully compare in purpose to Christ’s.  Second, humility allows 
individuals to refrain from making comparisons between one another, using a measuring tool that 
directly correlates the behavior of a person with their level of suffering.  Having an illness or 
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having a child with an inherited condition should not be used as a moral “measuring stick” to 
determine whether the person or the parents have been moral or immoral.  Lastly, as with so 
many other things in life, humility is necessary in order to recognize that many times there is no 
clear answer or reason to certain illnesses, sufferings or deaths.  Our bodies are fragile. 
 
Sanctity of the body 
God recognizes that both the whole creation and human beings within it are very good.187  
Men and women are created in the image and likeness of God,188 and this creation includes the 
body.  One may question, if the human body was made good, and there is beauty in that 
goodness, then why is there such a great demand or desire to change one’s body?  The changes 
can be superfluous or temporary (hair color), long lasting (tattoos), and deeply transforming (any 
form of genetic modification).  There are too many reasons behind those changes.  Among the 
positive ones, the most obvious is that there is a natural desire to improve.  Among the reasons 
that should concern us, one is when some people are motivated by lack of love for themselves.  
What a painful reality, when people on their own or due to rejection from others, dislike or even 
hate who they are.  As family, friends, and faith communities, how important it is that we 
support each other in loving ourselves, no matter what illnesses, conditions or physical 
characteristics we have. 
Unfortunately, dualism between body and spirit is still lingering in some minds.  
Moreover, there are people and communities that view “the body as a disposable and not entirely 
worthy package for spirit.”189  When this mentality prevails, the result is that the spirit is the only 
thing that is seen as made in the image of God and the body is completely excluded.  As a result, 
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some become indifferent to their body or even reject it.  But the account of creation in Genesis 
does not “make a divide between human spirit and body, or attribute image only to spirit.”190  
When there seems to be no connection between the human body and God, it might be easier to 
randomly modify the body.  When there is a Christian understanding of the body, then there is a 
clear appreciation of its dignity, and being part of the body of Christ and temple of the Spirit.191  
With this knowledge in mind, the random desires to modify or edit the body can be seen almost 
as a “desecration of the body.”192  Therefore, as individuals and as communities, we all need to 
move towards a greater appreciation of the human body and its role in our spiritual growth, and 
avoid seeing it as an obstacle.  Luke T. Johnson summarizes the rightful role of the body by 
saying that “the human body not only can reveal God, it is the privileged medium of divine self-
disclosure.”193  Our bodies and senses have been among the most effective ways in which God 
self-reveals.  And God’s self-revelation to us never stops, and our challenge to keep learning 
more about God and to love God in ourselves, others, and in creation, does not stop either. 
Many people believe that science and theology are nemesis in the search of truth, when 
actually science has, can, and should join theology’s task of discerning God’s revelation and 
will.  If scientific knowledge and discoveries are part of the culture of a people, it has been 
obvious in our Judeo-Christian beliefs, as in all other religions, the impact that culture has on 
those beliefs.194  The opposite is also true: religious beliefs have a great impact on the culture of 
a community, and that includes their scientific interpretations.  It is important to acknowledge 
that scientific developments in regards to the body impacted our theology and spirituality.  For 
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example, in biblical times most illnesses were seen quite often as a punishment from God, until 
later on when viruses and bacteria, and their impact on the body, were discovered.  As late as the 
twentieth-century, some ethnical groups were seen as inferior and imperfect, until genetic 
information among other things, confirmed our equality and similarities.  What remains to be 
discovered about our bodies is the task of the current and future generation.  As with our 
ancestors, there are things we know about our bodies that maybe two hundred, or just twenty 
years from now, will prove our present knowledge as erroneous.   
How do we consider the interaction between science and theology?  Robert J. Russell 
presents Ian G. Barbour’s proposed four main dynamics: conflict, independence, dialogue, and 
interaction.195  Conflict is mostly seen in scientific atheism: everything can be explained 
scientifically and there is no space for God.  Some religious groups took a defensive (and 
sometimes offensive) position.  Another model is when science and religion are seen as “totally 
independent of each other;”196 each one focused on their own field of studies.  With dialogue, 
there is an acknowledgement of the historical contribution by which they fostered each other, 
and also the role of theology to try to explain questions that “point beyond science.”197  Lastly, 
interaction provides for the opportunity “of genuine and mutual two-way exchange and fruitful 
growth in our theological and scientific understanding of the universe and humanity.”198  I agree 
with Russell and Barbour that science and theology cannot be kept apart by conflict or 
independence.  Science and theology should be engaged in dialogue and interaction.  This 
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implies that theology must take seriously the scientific discoveries, and that science cannot 
discard theological reflections and assumptions which cannot be empirically explained.199   
With the previous discussion about God’s revelation and the sanctity of the body in mind, 
we should rephrase what we asked throughout these chapters.  Besides asking what are the 
reasons or purposes for genetic editing, we should now also add what does genetic editing reveal 
about our bodies, about our imago Dei, and about God.  Is the goal to heal, to carry on God’s 
creative actions, to make that reign of God more present in our midst, or to ‘just’ modify the 
body?  In regards to healing, the Catechism of the Catholic Church affirms:  “Life and physical 
health are precious gifts entrusted to us by God.  We must take reasonable care of them, taking 
into account the needs of others and the common good.”200  Because they are “precious gifts” 
there is an obligation to look after the well-being of the person.  There is a call to use our 
wisdom, technology, and natural resources to protect and improve the health of those who are 
sick.  This call to duty is limited by justice.  The Church clearly acknowledges that care should 
be “reasonable;” it cannot favor a small segment of society by consuming an excessive amount 
of resources available in order to help them.  She expects the entire community to keep in mind 
the “needs of others,” not to focus on benefiting only a few people.  
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How is genetic editing leading us closer to God?  Everything we do in our earthly journey 
in one way or another should improve or enhance our lives in order to make us wholesome.  
Based on our study, being wholesome should include among many things: overcoming illnesses, 
being restored within society, the ability to recognize God’s presence and creative work, using 
God’s gifts and acknowledging that they are God-given, and seeing the goodness in the whole 
creation.  It is important that all these things are happening, so that when we move forward with 
genetic editing, because it seems already occurring, this editing should uphold the innate 
goodness by which every individual is created. 
Hopefully, people discerning if they should engage in genetic editing research and 
clinical trials will find in their ecclesial communities a place and opportunity to have a 
conversation about these issues.  Pastoral leaders should be ready to support the procedures that 
foster health improvements and, at the same time, maintain the dignity of the person.  Moreover, 
they should be able to challenge those treatments that reduce the person (adult, child, or embryo) 
to an object that is being used mainly for the benefit of researchers and private companies 
fostering the research.   
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Saint Thomas Aquinas made an interesting distinction between studiositas (studiousness) 
versus curiositas (curiosity).  According to him, studiositas is positive desire for knowledge and 
curiositas is negative desire for knowledge.201  When dealing with genetic editing, Aquinas’ 
negative knowledge applies if, for example, the main motivation behind genetic discoveries and 
experimentation is financial enrichment.  Probably, Aquinas would not suggest to stop research 
on genetic editing in some cases, but what he would ask is to make sure that scientists are not 
‘fooling around’ or tampering with the human body just to see what they can find or discover.   
At every stage of research, during clinical trials, and in the case of future 
implementations of genetic editing, it is critical to foster a society that recognizes the dignity of 
every person–even when ill or with a disability.  This includes treating the person with respect 
and love, and finding the best ways to address their condition.  The goal is to avoid ever looking 
down at persons as if they have worthless lives due to their situation or condition.  Charity is 
always needed even in the case of genetic editing.  It is necessary to promote love for one’s 
neighbor, and as Pope Benedict XVI said, more than a neighbor, our brothers.202  For Christians, 
the ultimate goal is to build the kingdom of heaven here on earth.  Therefore, we need look at 
what is happening in laboratories and hospitals, and the reasons that justify what is being done, 
to see if it responds to an authentic and loving desire to improve, heal, and serve all peoples, our 
brothers and sisters. 
If we look at Jesus’ ministry, we can see how God wants us healthy, well fed, and joyful.  
It is very obvious that God provided men and women with great wisdom, and nature with 
amazing resources.  It would be a failure and betrayal to the vocation of scientists, researchers, 
and anyone else in the medical field if we did not use our God-given gifts and talents to do the 
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best we could to heal someone.  The call to heal is beautiful.  But even these healing vocations 
have an essential moral limitation: the healing of one cannot be achieved by hurting another.   
Two basic tasks remain at hand: finding cures for illnesses and supporting individuals as 
they deal with illnesses (as patient or caregiver).  In both tasks, it is important to cultivate the 
virtues of patience, charity, and humility.  In spite of the number of scientists involved in 
medical research, we are still facing many illnesses.  How to cope with these health struggles?  If 
we believe in the wisdom of Scripture, as caregivers, Jesus reminds us to love another as he has 
loved us and that there is no greater love than to actually give one’s life for someone else–after 
careful discernment.  In caring for someone we respond to Christ’s call to divine love.  For 
Terrence W. Tilley, “We have come to take the practice of medicine as ‘curing diseases’ and 
‘beating death’ rather than ‘caring for people.’”203  All those who are providing and receiving 
health care in homes, hospitals, and nursing homes should experience support and even love 
from family, friends, coworkers, and especially from faith communities. 
Both in the case of caregivers and the sick, Jesus invites all those who are burdened or 
tired to come to him.  He offers relief.  Sometimes we forget this promise and believe that we 
have no help.  But this would be “egocentric ambition to secure their health and improve their 
quality of life by relying exclusively on their own power, wisdom, and technical means.”204  In 
either scenario, whether it is struggling with an illness or finding a cure in a lab, what a 
difference when Christ is walking along! 
Throughout this research, one challenge was to adapt and implement theological 
arguments to address new scientific advancements.  As Christians, it is easier to grasp and 
explain to someone else the morality of an issue when there is a clear biblical reference, 
                                                          
203 Tilley, The Disciples’ Jesus, 148. 
204 See Koios, “Theological Anthropology,” 187. 
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especially if it refers to Jesus.  I am convinced that it is a challenge for pastoral staff and moral 
theologians to respond with the same conviction and authority to everything that is happening in 
the realm of new biological discoveries, and to faithfully articulate one’s arguments. 
When I asked the children of my parish what they knew about genetic mutations, the 
answers I got were: humans could fly, and could have extraordinary strength.  They sounded 
excited about the ‘super powers’ obtained by the characters in movies like X-Men, which is an 
imaginary world with a growing number of mutated humans.  In the real world, most human 
genetic mutations cause illnesses, and there is nothing exciting about that.  Genetic editing can 
be an opportunity to correct the genetic mutations causing these illnesses.  At these early stages, 
CRISPR/Cas9 seems to be financially affordable for the upper class and maybe even the middle 
class of society.  Maybe in a few years, like other vaccines and medications in the past, it could 
become more accessible for everyone.  It seems like there will be ways of engaging in some 
human trials without disregarding the needed respect for human dignity and for one’s identity.  
Unfortunately, some of the human trials will involve using embryos and even discarding some of 
them, and that will not be applauded or supported by Catholic official teaching. 
In summary, Catholic moral teaching supports genetic editing in adults with somatic 
illnesses, if it can be performed safely and with health benefits for the person.  If the 
modification takes place in the germline, the common concern is that no one knows its impact on 
future generations.  A moratorium has been asked on these experimentations. 
At the present time, IVF would be necessary for germline editing.  As common as IVF 
may be, it is not accepted by the Church’s Magisterium.   
As much as we want ourselves and our loved ones to be healthy and flourish, genetic 
editing for enhancement is seen with suspicion by researchers and ethicists alike. 
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I am aware of the ongoing developments in genetic editing.  Therefore, by the time you 
finished reading this paper, something new already happened.  With that in mind, I hope and 






We “participate in the creative power of God 
and are called to transform creation 
by ordering its many resources toward the dignity and wellbeing of all human beings  
and of the human person in his entirety.” 








Catechism of the Catholic Church.  2nd ed.  Washington, D.C.: United States Catholic  
Conference, 2000. 
 
The New American Bible.  Wichita, KS: Saint Jerome Press, 1991. 
 
Aquinas, Thomas.  Summa of the Summa.  Edited and annotated by Peter Kreeft.  San Francisco:  
Ignatius Press, 1990. 
 
Basil the Great.  “Question 55” in “The Long Rules.”  St. Basil: Ascetical Works.  Translated by  
M. Monica Wagner.  In The Fathers of the Church: A New Translation, 9, 330-337. 
Washington, D.C.: Catholic University of America Press, 1962.   
 
Benedict XVI.  Caritas in veritate.  2009. 
 
Cahill, Lisa Sowle.  Theological Bioethics: Participation, Justice, and Change.   
Washington, D.C.: Georgetown University Press, 2005. 
 
Congregation for the Doctrine of the Faith.  Dignitas personae: On Certain Bioethical  
Questions.  2008. 
 
Congregation for the Doctrine of the Faith.  Donum Vitae.  1987. 
 
Erasmus, Desiderius.  “Preparing for death.”  Translated by John N. Grant.  In Spiritualia and  
Pastoralia, Collected Works of Erasmus, 70, edited by John W. O’Malley.  Toronto:  
University of Toronto Press, 1998. 
 
Heller, Jan C.  “Using Human Dignity to Constrain Genetic Research and Development: When It  
Works and When It Does Not.”  In Genetics and Ethics: An Interdisciplinary Study.  
Edited by Gerard Magill, 116-125.  St. Louis: Saint Louis University Press, 2004.   
 
Johnson, Luke Timothy.  The Revelatory Body: Theology as Inductive Art.  Grand Rapids, MI:  
William B. Eerdmans, 2015. 
 
Keenan, James F., SJ.  “What Does Virtue Ethics Bring to Genetics?”  In Genetics, Theology,  
Ethics: An Interdisciplinary Conversation, edited by Lisa Sowle Cahill, 97-113.   
New York: Crossroads/Herder, 2005. 
 
Messer, Neil G.  Respecting Life: Theology and Bioethics.  London: SCM Press, 2011. 
 
National Academy of Sciences, Engineering, and Medicine.  Human Genome Editing: Science,  




Parrington, John.  Redesigning Life: How Genome Editing will Transform the World.  Oxford:  
Oxford University Press, 2016. 
 
Peterson, James C.  Genetic Turning Points: The Ethics of Human Genetic Intervention.  Grand  
Rapids, MI: William B. Eerdmans, 2001. 
 
Reilly, Philip R.  Orphan: The Quest to Save Children with Rare Genetic Disorders.  Cold  
Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2015. 
 
Russell, Robert John.  “The Contributions of the Natural Sciences to the Academic Discipline of  
Christian Spirituality.”  In Exploring Christian Spirituality: Essays in Honor of Sandra  
M. Schneiders, IHM, edited by Bruce H. Lescher and Elizabeth Liebert, SNJM, 119-141.  
Mahwah, NJ: Paulist Press, 2006. 
 
Song, Robert.  Human Genetics:  Fabricating the Future.  Cleveland, OH:  The Pilgrim Press,  
2002. 
 
Tilley, Terrence W.  The Disciples’ Jesus: Christology as Reconciling Practice.  Maryknoll, NY:  
Orbis Books, 2008. 
 
Turksen, Kursad, ed.  Genome Editing.  Switzerland: Springer, 2016. 
 
Vogt, Christopher P.  Patience, Compassion, Hope, and the Christian Art of Dying Well.  
Lanham, MD: Rowman & Littlefield, 2004. 
 





Board of Directors of the American College of Medical Genetics and Genomic.  “Genome  
editing in clinical genetics: points to consider–A statement of the American College of  
Medical Genetics and Genomics.”  Genetics in Medicine 19, no. 7 (July 2017): 723-724. 
 
Drake, Tim.  “Tattoo Taboos–Catholics Debate the Morality of Body Art.”  National Catholic  
Register 84, no. 35 (September 7, 2008): 1-3. 
 
Duroux-Richard, Isabelle, Carine Giovabbabgeli and Florence Apparailly.  “CRISPR-Cas9: A  
revolution in genome editing in rheumatic diseases.”  Joint Bone Spine 84 (2017): 1-4. 
 
Hung, Sandy S.C., Tristan MCaughey, Olivia Swann, Alice Pébay, and Alex W. Hewitt.   
“Genome engineering in ophthalmology: Application of CRISPR/Cas9 to the treatment  
of eye disease.”  Progress in Retinal and Eye Research 53 (2016): 1-20. 
 
Jones, David A.  “Germ-line Genetic Engineering: a Critical Look at Magisterial Catholic  
Teaching.”  Christian Bioethics 18, no. 2 (2012): 126-144. 
97 
 
Keenan, James F., SJ.  “Perfecting Ourselves: On Christian Tradition and Enhancement.”   
Southern Medical Journal 100, no. 1 (January 2007): 96-97.  
 
Keenan, James F., SJ.  “Proposing Cardinal Virtues.”  Theological Studies 56, no. 4 (1995):  
709-729. 
 
Koios, Nikolaos.  “Theological Anthropology and Human Germ-Line Intervention.”  Christian  
Bioethics 18, no. 2 (August 2012):  187-200. 
 
Messer, Neil G.  “Human Genetics and Theological Ethics.”  The Expository Times 124, no. 12  
(2013): 573-581. 
 
Mulvihill, John J., Benjamin Capps, Yann Joly, Tamra Lysaght, Hub A. E. Zwart, and  
Ruth Chadwick, The International Human Genome Organisation (HUGO) Committee of  
Ethics, Law, and Society (CELS).  “Ethical issues of CRISPR technology and gene 
editing through the lens of solidarity.”  British Medical Bulletin 122, no. 1 (2017): 17-29. 
 
Ormond, Kelly E., Douglas P. Mortlock, Derek T. Scholes, Yvonne Bombard, Lawrence C.  
Brody, W. Andrew Faucett, Nanibaa’ A. Garrison, Laura Hercher, Rosario Isasi, Anna  
Middleton, Kiran Musunuru, Daniel Shriner, Alice Virani, and Caroline E. Young.   
“Human Germline Genome Editing”  The American Journal of Human Genetics 101,  
no. 2 (August 3, 2017), 167–176. 
 
Pollack, Robert.  “Eugenics lurk in the shadow of CRISPR.”  Science 348, no. 6237 
(May 22, 2015): 871. 
 
Prentice, David A.  “Science.”  The National Catholic Bioethics Quarterly 18, no. 2 (Summer  
2018): 331-341. 
 
Ritch, James Mary, O.P.  “Human Gene Editing: A Century of Tears to a Century of Fears?”   




Waters, Brent P.  “Christian Ethics and Human Germ Line Genetic Modification.”  Christian  




“Federal Policy for the Protection of Human Subjects.”  Federal Register 82, no.12  
(January 19, 2017): 7266.  Last accessed 11/4/2019.  https://www.gpo.gov/fdsys/pkg/FR-
2017-01-19/html/2017-01058.htm. 
 





Merriam-Webster Dictionary.  Last accessed 11/4/2019.   
https://www.merriam-webster.com/dictionary. 
 
Augustine.  City of God.  Last accessed 11/4/2019.  www.newadvent.org/fathers/120114.htm. 
 
Council for International Organizations of Medical Sciences.  International Ethical Guidelines  




De Luca, Carmela and Ainslie Parsons.  “Another Round in the US CRISPR Patent Dispute.”   
Last accessed 11/4/2019.  https://www.mondaq.com/unitedstates/x/847330/ 
Patent/Another+Round+In+The+US+CRISPR+Patent+Dispute. 
 
Kolata, Gina, Sui-Lee Wee, and PamBelluck.  “Chinese Scientist Claims to Use Crispr to Make  
First Genetically Edited Babies.” The New York Times, November 26, 2018.  
Last accessed 11/4/2019.  https://www.nytimes.com/2018/11/26/health/gene-editing- 
babies-china.html. 
 
National Institutes of Health, Office of Science Policy.  Last accessed 11/4/2019.   
https://osp.od.nih.gov/biotechnology/recombinant-dna-advisory-committee/. 
 




RNA.  Last accessed 11/4/2019. 
https://www.genome.gov/genetics-glossary/RNA-Ribonucleic-Acid. 
 
Sheen, Archbishop Fulton J. “The Divine Romance: Dying and Behold We Live.”   
Last accessed 11/4/2019.  
https://www.catholicculture.org/culture/library/view.cfm?recnum=3787. 
 
UNESCO. Universal Declaration on Bioethics and Human Rights.  October 19, 2005.  
Last accessed 11/4/2019.  http://portal.unesco.org/en/ev.php- 
URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html 
 




US Congress.  Consolidated Appropriations Act of 2016, HR 2029, 114 Congress,  
1st session (January 5, 2015).  Last accessed 11/4/2019. 
https://www.congress.gov/bill/114th-congress/house- bill/2029/text. 
 
